FALSE2020Q2000173318612/314.000.04481790000.057142800000017331862020-01-012020-06-30xbrli:shares00017331862020-07-17iso4217:USD00017331862020-04-012020-06-3000017331862019-04-012019-06-3000017331862019-01-012019-06-30iso4217:USDxbrli:shares00017331862020-06-3000017331862019-12-31xbrli:pure0001733186vne:A4ConvertibleSeniorNotesDue2024Memberus-gaap:ConvertibleNotesPayableMember2020-06-300001733186us-gaap:CommonStockMember2019-12-310001733186us-gaap:AdditionalPaidInCapitalMember2019-12-310001733186us-gaap:RetainedEarningsMember2019-12-310001733186us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001733186us-gaap:NoncontrollingInterestMember2019-12-310001733186us-gaap:RetainedEarningsMember2020-01-012020-06-300001733186us-gaap:NoncontrollingInterestMember2020-01-012020-06-300001733186us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-06-300001733186us-gaap:AdditionalPaidInCapitalMember2020-01-012020-06-300001733186us-gaap:CommonStockMember2020-06-300001733186us-gaap:AdditionalPaidInCapitalMember2020-06-300001733186us-gaap:RetainedEarningsMember2020-06-300001733186us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001733186us-gaap:NoncontrollingInterestMember2020-06-300001733186us-gaap:CommonStockMember2018-12-310001733186us-gaap:AdditionalPaidInCapitalMember2018-12-310001733186us-gaap:RetainedEarningsMember2018-12-310001733186us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001733186us-gaap:NoncontrollingInterestMember2018-12-3100017331862018-12-310001733186us-gaap:RetainedEarningsMember2019-01-012019-06-300001733186us-gaap:NoncontrollingInterestMember2019-01-012019-06-300001733186us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-06-300001733186us-gaap:AdditionalPaidInCapitalMember2019-01-012019-06-300001733186us-gaap:CommonStockMember2019-01-012019-06-300001733186us-gaap:CommonStockMember2019-06-300001733186us-gaap:AdditionalPaidInCapitalMember2019-06-300001733186us-gaap:RetainedEarningsMember2019-06-300001733186us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-300001733186us-gaap:NoncontrollingInterestMember2019-06-3000017331862019-06-300001733186us-gaap:SpinoffMembervne:AutolivIncMember2018-06-292018-06-290001733186us-gaap:SpinoffMembervne:AutolivIncMemberus-gaap:CommonStockMember2018-06-292018-06-290001733186us-gaap:SpinoffMembervne:AutolivIncMembervne:SwedishDepositoryReceiptsMember2018-06-292018-06-29vne:segment00017331862019-05-282019-05-280001733186vne:A4ConvertibleSeniorNotesDue2024Memberus-gaap:ConvertibleNotesPayableMember2019-05-280001733186us-gaap:OverAllotmentOptionMembervne:A4ConvertibleSeniorNotesDue2024Memberus-gaap:ConvertibleNotesPayableMember2019-05-2800017331862019-05-280001733186vne:A4ConvertibleSeniorNotesDue2024Memberus-gaap:ConvertibleNotesPayableMember2019-05-282019-05-280001733186us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembervne:HondaVNBSProductLineMember2019-10-300001733186us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembervne:HondaVNBSProductLineMember2020-02-03vne:transaction00017331862020-06-302020-06-300001733186vne:ResearchDevelopmentAndImplementationOfChangeMember2020-05-202020-05-200001733186vne:FutureSoftwareDevelopmentMember2020-05-202020-05-200001733186vne:ResearchDevelopmentAndSoftwareAdjustmentAgreementMember2020-04-012020-06-300001733186vne:EngineeringServicesMember2020-01-012020-06-300001733186us-gaap:OtherCurrentLiabilitiesMember2020-06-300001733186us-gaap:CustomerConcentrationRiskMembervne:FourLargestCustomersMemberus-gaap:RevenueFromContractWithCustomerMember2020-04-012020-06-300001733186us-gaap:CustomerConcentrationRiskMembervne:FourLargestCustomersMemberus-gaap:RevenueFromContractWithCustomerMember2020-01-012020-06-300001733186us-gaap:CustomerConcentrationRiskMembervne:FourLargestCustomersMemberus-gaap:RevenueFromContractWithCustomerMember2019-04-012019-06-300001733186us-gaap:CustomerConcentrationRiskMembervne:FourLargestCustomersMemberus-gaap:RevenueFromContractWithCustomerMember2019-01-012019-06-300001733186us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembervne:FourLargestCustomersMember2020-06-302020-06-300001733186us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembervne:FourLargestCustomersMember2019-12-312019-12-310001733186us-gaap:AccountingStandardsUpdate201602Member2019-01-010001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:AsiaMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:AsiaMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembersrt:AsiaMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:AsiaMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:AsiaMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembersrt:AsiaMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:AmericasMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:AmericasMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembersrt:AmericasMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:AmericasMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:AmericasMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembersrt:AmericasMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:EuropeMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:EuropeMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembersrt:EuropeMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:EuropeMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:EuropeMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembersrt:EuropeMember2019-04-012019-06-300001733186vne:ElectronicsSegmentMember2020-04-012020-06-300001733186vne:BrakeSystemsSegmentMember2020-04-012020-06-300001733186vne:ElectronicsSegmentMember2019-04-012019-06-300001733186vne:BrakeSystemsSegmentMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:AsiaMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:AsiaMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembersrt:AsiaMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:AsiaMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:AsiaMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembersrt:AsiaMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:AmericasMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:AmericasMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembersrt:AmericasMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:AmericasMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:AmericasMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembersrt:AmericasMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:EuropeMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:EuropeMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembersrt:EuropeMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembersrt:EuropeMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembersrt:EuropeMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembersrt:EuropeMember2019-01-012019-06-300001733186vne:ElectronicsSegmentMember2020-01-012020-06-300001733186vne:BrakeSystemsSegmentMember2020-01-012020-06-300001733186vne:ElectronicsSegmentMember2019-01-012019-06-300001733186vne:BrakeSystemsSegmentMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:RestraintControlSystemsMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:RestraintControlSystemsMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:RestraintControlSystemsMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:RestraintControlSystemsMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:RestraintControlSystemsMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:RestraintControlSystemsMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:ActiveSafetyProductsMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:ActiveSafetyProductsMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ActiveSafetyProductsMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:ActiveSafetyProductsMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:ActiveSafetyProductsMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ActiveSafetyProductsMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:BrakeSystemsMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:BrakeSystemsMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:BrakeSystemsMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:BrakeSystemsMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:RestraintControlSystemsMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:RestraintControlSystemsMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:RestraintControlSystemsMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:RestraintControlSystemsMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:RestraintControlSystemsMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:RestraintControlSystemsMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:ActiveSafetyProductsMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:ActiveSafetyProductsMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ActiveSafetyProductsMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:ActiveSafetyProductsMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:ActiveSafetyProductsMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ActiveSafetyProductsMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:BrakeSystemsMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:BrakeSystemsMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMembervne:BrakeSystemsMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMembervne:BrakeSystemsMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsMember2019-01-012019-06-3000017331862020-01-012020-03-310001733186us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembervne:BrakeSystemsSegmentMember2020-06-300001733186us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembervne:HondaVNBSProductLineMember2019-10-302019-10-300001733186us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembervne:HondaVNBSProductLineMember2019-12-310001733186vne:A4ConvertibleSeniorNotesDue2024Memberus-gaap:ConvertibleNotesPayableMember2019-12-310001733186us-gaap:SecuredDebtMembervne:OtherLongTermBorrowingsMember2020-06-300001733186us-gaap:SecuredDebtMembervne:OtherLongTermBorrowingsMember2019-12-3100017331862020-04-2400017331862020-06-252020-06-25vne:tradingDay0001733186srt:MinimumMember2019-05-282019-05-280001733186srt:MinimumMembervne:A4ConvertibleSeniorNotesDue2024Memberus-gaap:ConvertibleNotesPayableMember2019-05-282019-05-280001733186srt:MaximumMembervne:A4ConvertibleSeniorNotesDue2024Memberus-gaap:ConvertibleNotesPayableMember2019-05-282019-05-28vne:contract0001733186us-gaap:ForeignExchangeContractMembervne:MaturityBeyondSixMonthsMember2020-06-300001733186us-gaap:ForeignExchangeContractMembersrt:MaximumMember2020-01-012020-06-300001733186us-gaap:ForeignExchangeForwardMember2020-06-300001733186us-gaap:ForeignExchangeForwardMember2019-12-310001733186us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2017-06-300001733186us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-06-300001733186us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2019-12-310001733186us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2020-01-012020-06-3000017331862020-03-31vne:investment0001733186vne:ZenuityABMember2020-04-02iso4217:SEK0001733186vne:ZenuityABMember2020-04-012020-06-300001733186vne:ZenuityABMember2020-06-300001733186vne:ZenuityABMember2020-01-012020-03-310001733186vne:ZenuityABMember2020-03-310001733186vne:ZenuityABMember2020-01-012020-06-300001733186vne:ZenuityABMember2019-04-012019-06-300001733186vne:ZenuityABMember2019-01-012019-06-300001733186vne:ZenuityABMember2019-12-310001733186srt:AffiliatedEntityMember2020-06-300001733186srt:AffiliatedEntityMember2019-12-310001733186us-gaap:PensionPlansDefinedBenefitMembervne:ExistingVeoneerPlansMember2020-04-012020-06-300001733186us-gaap:PensionPlansDefinedBenefitMembervne:ExistingVeoneerPlansMember2019-04-012019-06-300001733186us-gaap:PensionPlansDefinedBenefitMembervne:ExistingVeoneerPlansMember2020-01-012020-06-300001733186us-gaap:PensionPlansDefinedBenefitMembervne:ExistingVeoneerPlansMember2019-01-012019-06-300001733186vne:TwoThousandEighteenStockIncentivePlanMember2018-06-290001733186us-gaap:SpinoffMembervne:TwoThousandEighteenStockIncentivePlanMembervne:AutolivIncMember2018-06-292018-06-290001733186vne:TwoThousandEighteenStockIncentivePlanMember2018-06-292018-06-290001733186us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-06-300001733186us-gaap:PerformanceSharesMember2020-01-012020-06-300001733186vne:RestrictedStockUnitsAndPerformanceSharesMember2020-01-012020-06-300001733186srt:MinimumMember2020-01-012020-06-300001733186srt:MaximumMember2020-01-012020-06-300001733186vne:RestrictedStockUnitsAndPerformanceSharesMember2020-04-012020-06-300001733186vne:RestrictedStockUnitsAndPerformanceSharesMember2019-04-012019-06-300001733186vne:RestrictedStockUnitsAndPerformanceSharesMember2019-01-012019-06-3000017331862019-03-310001733186us-gaap:StockCompensationPlanMember2020-04-012020-06-300001733186us-gaap:StockCompensationPlanMember2020-01-012020-06-300001733186us-gaap:StockCompensationPlanMember2019-04-012019-06-300001733186us-gaap:StockCompensationPlanMember2019-01-012019-06-300001733186us-gaap:ConvertibleDebtSecuritiesMember2020-04-012020-06-300001733186us-gaap:ConvertibleDebtSecuritiesMember2020-01-012020-06-300001733186us-gaap:ConvertibleDebtSecuritiesMember2019-04-012019-06-300001733186us-gaap:ConvertibleDebtSecuritiesMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:ElectronicsSegmentMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMembervne:BrakeSystemsSegmentMember2019-01-012019-06-300001733186us-gaap:OperatingSegmentsMember2020-04-012020-06-300001733186us-gaap:OperatingSegmentsMember2019-04-012019-06-300001733186us-gaap:OperatingSegmentsMember2020-01-012020-06-300001733186us-gaap:OperatingSegmentsMember2019-01-012019-06-300001733186us-gaap:CorporateNonSegmentMember2020-04-012020-06-300001733186us-gaap:CorporateNonSegmentMember2019-04-012019-06-300001733186us-gaap:CorporateAndOtherMember2020-01-012020-06-300001733186us-gaap:CorporateAndOtherMember2019-01-012019-06-300001733186vne:TransitionServicesAgreementMembersrt:AffiliatedEntityMembervne:AutolivIncMember2020-04-012020-06-300001733186vne:TransitionServicesAgreementMembersrt:AffiliatedEntityMembervne:AutolivIncMember2019-04-012019-06-300001733186vne:TransitionServicesAgreementMembersrt:AffiliatedEntityMembervne:AutolivIncMember2019-01-012019-06-300001733186vne:VeoneerNissinBrakesSystemsMember2020-06-300001733186vne:TransitionServicesAgreementMembersrt:AffiliatedEntityMembervne:AutolivIncMembervne:VeoneerNissinBrakesSystemsMember2020-06-300001733186srt:AffiliatedEntityMembervne:AutolivIncMember2020-04-012020-06-300001733186srt:AffiliatedEntityMembervne:AutolivIncMember2020-01-012020-06-300001733186srt:AffiliatedEntityMembervne:AutolivIncMember2019-04-012019-06-300001733186srt:AffiliatedEntityMembervne:AutolivIncMember2019-01-012019-06-300001733186vne:VolvoCarsMembervne:ZenuityABMember2020-04-02vne:numberOfSoftwareEngineers00017331862020-04-020001733186us-gaap:SubsequentEventMember2020-07-022020-07-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2020
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File No.: 001-38471

Veoneer, Inc.
(Exact name of registrant as specified in its charter)
Delaware 82-3720890
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
   
Klarabergsviadukten 70, Section C6  
Box 13089  
Stockholm Sweden
(Address of principal executive offices)
SE- 103 02
(Zip Code)
+46 8 527 762 00
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock, $1.00 par value VNE New York Stock Exchange
        Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes:   No: 
        Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes:      No:  
        Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer  
  Accelerated filer  
Non-accelerated filer  
  Smaller reporting company  
Emerging Growth Company  
       
 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes:      No:   
Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date: As of July 17, 2020, there were 111,594,577 shares of common stock of Veoneer, Inc., par value $1.00 per share, outstanding.
Exhibit index located on page 42



FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including without limitation, statements regarding management’s examination of historical operating trends and data, estimates of future sales (including estimates related to order intake), operating margin, cash flow, RD&E spend, taxes or other future operating performance or financial results, are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “may,” “likely,” “might,” “would,” “should,” “could,” or the negative of these terms and other comparable terminology, although not all forward-looking statements contain such words. We have based these forward-looking statements on our current expectations and assumptions and/or data available from third parties about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs.
New risks and uncertainties arise from time to time, and it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Factors that could cause actual results to differ materially from these forward-looking statements include, without limitation, the following: general economic conditions; the impact of the coronavirus (COVID-19) on the Company’s financial condition, business operations and liquidity; the impact of COVID-19 on our customers and their production and product launch schedules; our ability to complete the divestiture of Veoneer Brake Systems ("VBS"), which is subject to the negotiation and documentation of a definitive agreement and closing; the cyclical nature of automotive sales and production; changes in general industry and market conditions or regional growth or decline; further decreases in light vehicle production; our ability to achieve the intended benefits from our separation from our former parent; our ability to be awarded new business or loss of business from increased competition; higher than anticipated costs and use of resources related to developing new technologies; higher raw material, energy and commodity costs; component shortages; changes in customer and consumer preferences for end products; market acceptance of our new products; dependence on and relationships with customers and suppliers; our ability to share RD&E costs with our customers; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; costs or difficulties related to the integration of any new or acquired businesses and technologies; successful integration of acquisitions and operations of joint ventures; successful implementation of strategic partnerships and collaborations; product liability, warranty and recall claims and investigations and other litigation and customer reactions thereto; higher expenses for our pension and other post-retirement benefits, including higher funding needs for our pension plans; work stoppages or other labor issues; possible adverse results of future litigation, regulatory actions or investigations or infringement claims; our ability to protect our intellectual property rights; tax assessments by governmental authorities and changes in our tax rate; dependence on key personnel; legislative or regulatory changes impacting or limiting our business; political conditions; and other risks and uncertainties identified in Part I Item 2 - “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and Part II, Item 1A -“Risk Factors” and in this Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission ("SEC") on February 21, 2020.
For any forward-looking statements contained in this Quarterly Report on Form 10-Q or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.
2


Veoneer, Inc.
Table of Contents
Page
 
4
 
4
 
25
39
39
 
40
40
40
41
41
41
 
41
42
 
43

3


Part I – Financial Information
Item 1 – Condensed Consolidated Financial Statements
Veoneer, Inc.
Condensed Consolidated Statements of Operations (Unaudited)
(U.S. DOLLARS IN MILLIONS EXCEPT PER SHARE DATA)

    Three Months Ended June 30 Six Months Ended June 30
    2020 2019 2020 2019
Net sales Note 3 $ 184    $ 489    $ 546    $ 984   
Cost of sales   (181)   (412)   (490)   (822)  
Gross profit     77    56    162   
Selling, general and administrative expenses   (38)   (50)   (82)   (102)  
Research, development and engineering expenses, net   (44)   (159)   (175)   (315)  
Amortization of intangibles   (1)   (6)   (3)   (11)  
Other income, net   16      18     
Operating loss   (64)   (137)   (186)   (265)  
Loss on divestiture and assets held for sales, net Note 4 —    —    (67)   —   
Loss from equity method investment Note 9 (19)   (18)   (38)   (35)  
Interest income          
Interest expense   (5)   (2)   (10)   (3)  
Other non-operating items, net   (3)     (1)    
Loss before income taxes Note 15 (88)   (152)   (295)   (294)  
Income tax (expense) benefit Note 7 (2)   10    (26)    
Net loss   (90)   (142)   (321)   (290)  
Less: Net income (loss) attributable to non-controlling interest   —    (9)     (20)  
Net loss attributable to controlling interest   $ (90)   $ (133)   $ (322)   $ (270)  
Net loss per share - basic Note 14 $ (0.80)   $ (1.39)   $ (2.89)   $ (2.94)  
Net loss per share - diluted   $ (0.80)   $ (1.39)   $ (2.89)   $ (2.94)  
Weighted average number of shares outstanding, (in millions)   111.58    96.06    111.52    91.68   
Weighted average number of shares outstanding, assuming dilution (in millions)   111.58    96.06    111.52    91.68   
See notes to the unaudited condensed consolidated financial statements.

4


Veoneer, Inc.
Condensed Consolidated Statements of Comprehensive Loss (Unaudited)
(U.S. DOLLARS IN MILLIONS)
  Three Months Ended June 30 Six Months Ended June 30
  2020 2019 2020 2019
Net loss $ (90)   $ (142)   $ (321)   $ (290)  
Other comprehensive loss, before tax:
Change in cumulative translation adjustment 18    (2)   (3)   (13)  
Pension liability —    —      —   
Other comprehensive income (loss), before tax 18    (2)   (2)   (13)  
Expense for taxes —    —    —    —   
Other comprehensive income (loss), net of tax 18    (2)   (2)   (13)  
Comprehensive loss (72)   (144)   (323)   (303)  
Less: Comprehensive income (loss) attributable to non-controlling interest —    (7)     (18)  
Comprehensive loss attributable to controlling interest $ (72)   $ (137)   $ (324)   $ (285)  
See notes to the unaudited condensed consolidated financial statements.
5


Veoneer, Inc.
Condensed Consolidated Balance Sheets
(U.S. DOLLARS IN MILLIONS)
(unaudited)
June 30, 2020 December 31, 2019
Assets      
Cash and cash equivalents   $ 851    $ 859   
Receivables, net   206    253   
Inventories, net Note 8 132    144   
Related party receivables Note 16   11   
Prepaid expenses and other contract assets   29    47   
Other current assets   17    18   
Assets held for sale Note 4 17    317   
Total current assets   1,260    1,649   
Property, plant and equipment, net   406    473   
Operating lease right-of-use assets 93    100   
Equity method investment Note 9 74    87   
Goodwill 290    290   
Intangible assets, net 11    17   
Deferred tax assets      
Investments    
Other non-current assets   28    111   
Total assets   $ 2,177    $ 2,743   
Liabilities and equity      
Accounts payable   $ 131    $ 233   
Related party payables Note 16    
Accrued expenses Note 10 200    192   
Income tax payable   28     
Other current liabilities   63    38   
Liabilities held for sale Note 4   118   
Total current liabilities   429    591   
4.00% Convertible Senior Notes due 2024
Note 5 165    160   
Pension liability Note 11 17    17   
Deferred tax liabilities   11    13   
Operating lease non-current liabilities 75    82   
Finance lease non-current liabilities 38    33   
Other non-current liabilities   28    29   
Total non-current liabilities   334    334   
Equity      
Common stock  (par value $1.00, $325 million shares authorized, 111 million shares issued and outstanding as of June 30, 2020 and December 31, 2019)
  111    111   
Additional paid-in capital   2,347    2,343   
Accumulated deficit (1003)   (681)  
Accumulated other comprehensive loss   (41)   (44)  
Total equity   1,414    1,729   
Non-controlling interest   —    89   
Total equity and non-controlling interest   1,414    1,818   
Total liabilities, equity and non-controlling interest   $ 2,177    $ 2,743   
See notes to the unaudited condensed consolidated financial statements.
6


Veoneer, Inc.
Condensed Consolidated Statements of Changes in Equity (Unaudited)
(U.S. DOLLARS IN MILLIONS)
Six months ended June 30, 2020
  Equity attributable to
  Common Stock Additional Paid In Capital Accumulated Deficit Accumulated Other
Comprehensive Loss
Non-controlling
Interest
Total
Balance at beginning of period $ 111    $ 2,343    $ (681)   $ (44)   $ 89    $ 1,818   
Net loss —    —    (322)   —      (321)  
Foreign currency translation —    —    —    —       
     Stock based compensation expense —      —    —    —     
     Business divestitures —    —    —      (91)   (88)  
Balance at end of period $ 111    $ 2,347    $ (1,003)   $ (41)   $ —    $ 1,414   

Six months ended June 30, 2019
  Equity attributable to
  Common Stock Additional Paid In Capital Accumulated Deficit Accumulated Other
Comprehensive Loss
Non-controlling
Interest
Total
Balance at beginning of period $ 87    $ 1,938    $ (181)   $ (19)   $ 101    $ 1,927   
Comprehensive Income (Loss):
Net loss —    —    (270)   —    (20)   (290)  
Foreign currency translation —    —    —    (15)     (13)  
Stock based compensation expense —      —    —    —     
Issuance of common stock 24    379    —    —    —    403   
Purchase of minority interest —    (14)   —    —    14    —   
Equity component of issuance of convertible notes, net (Note 5) —    35 —    —    —    35   
Balance at end of period $ 111    $ 2,341    $ (451)   $ (34)   $ 97    $ 2,064   

7


Veoneer, Inc.
Condensed Consolidated Statements of Cash Flow (Unaudited)
(U.S. DOLLARS IN MILLIONS)
  Six Months Ended June 30
  2020 2019
Operating activities    
Net loss $ (321)   $ (290)  
Depreciation and amortization 46    60   
Gain on divestitures (77)   —   
Assets impairment charge 144    —   
Undistributed loss from equity method investments 38    35   
Stock-based compensation    
Deferred income taxes (1)   (4)  
Other, net (9)    
Change in operating assets and liabilities:
Receivables, gross 50    49   
Accrued expenses 22    15   
Related party receivables and payables, net   44   
Accounts payable (86)   (65)  
Prepaid expenses 29    (6)  
Inventories, gross 14     
Income taxes 21    —   
Other current assets and liabilities, net   (15)  
Net cash used in operating activities (116)   (160)  
Investing activities    
Proceeds from divestitures 176    —   
Capital expenditures (51)   (109)  
Equity method investment (25)   (11)  
Short-term investments mature into cash —     
Long term investments (1)   (4)  
Net cash provided by (used in) investing activities 99    (119)  
Financing activities    
Issuance of common stock
—    405   
Dividend paid to non-controlling interest (5)   —   
(Payments for) proceeds from long-term debt (1)   202   
Proceeds from short-term debt 15    20   
Net increase in related party short-term debt —     
Net cash provided by financing activities   629   
Effect of exchange rate changes on cash and cash equivalents —    (10)  
Increase (decrease) in cash and cash equivalents (8)   340   
Cash and cash equivalents at beginning of period 859    864   
Cash and cash equivalents at end of period $ 851    $ 1,204   
See notes to the unaudited condensed consolidated financial statements.
8


Veoneer, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
(U.S. DOLLARS IN MILLIONS)
Note 1. Basis of Presentation
Spin-Off
On June 29, 2018 (the “Distribution Date”), Veoneer, Inc. (“Veoneer” or “the Company”) became an independent, publicly-traded company as a result of the distribution by Autoliv, Inc. (“Autoliv” or “Former Parent”) of 100 percent of the outstanding common stock of Veoneer to the stockholders of Autoliv (the “Spin-Off”). Each Autoliv stockholder and holder of Autoliv’s Swedish Depository Receipts (SDRs) of record as of certain specified dates received one share of Veoneer common stock or one Veoneer SDR, respectively, for every one share of Autoliv common stock or Autoliv SDR. The Spin-Off was completed on June 29, 2018 in a tax free transaction pursuant to Section 355 of the U.S. Internal Revenue Code.
On July 2, 2018, Veoneer common stock began regular trading on the New York Stock Exchange (“NYSE”) under the ticker symbol “VNE” and Veoneer SDRs began trading on Nasdaq Stockholm under the symbol “VNE-SDB”. Agreements entered into between Veoneer and Autoliv in connection with the Spin-Off govern the relationship between the parties following the Spin-Off and provide for the allocation of various assets, liabilities, rights and obligations. These agreements also include arrangements for transition services to be provided on a temporary basis between the parties.
The Company has two operating segments, Electronics and Brake Systems. Electronics includes all electronics resources and expertise, Restraint Control Systems and Active Safety products, and Brake Systems provides brake control and actuation systems. The Asian business of the Brake Systems segment was sold on February 3, 2020 and the majority of the Brake Systems business in North America was sold subsequent to June 30, 2020. We do not expect the remaining Brake Systems business to be a reportable segment due to immateriality.

The accompanying unaudited condensed consolidated financial statements for Veoneer do not include all of the information and notes required by the accounting principles generally accepted in the U.S. (GAAP) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) and disclosures considered necessary for a fair presentation have been included. For further information, refer to Veoneer’s Audited Consolidated Financial Statements for the year ended December 31, 2019 and corresponding notes in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 21, 2020.
Certain amounts in the unaudited condensed consolidated financial statements and associated notes may not reconcile due to rounding. All percentages have been calculated using unrounded amounts.
Follow-on Offerings
On May 28, 2019, the Company completed follow-on public offerings of 24,000,000 shares of common stock and $207 million aggregate principal amount of 4.00% Convertible Senior Notes due 2024 (the “Notes”) (including $27 million aggregate principal amount pursuant to the underwriters’ over-allotment option to purchase additional notes). The public offering price for the Company's common stock offering was $17.50 per share. The Company received net proceeds of approximately $403 million from the common stock offering and approximately $200 million from the Notes offering, in each case after deducting the underwriting discounts and issuance costs directly attributable to each offering.
Divestiture of Veoneer Nissin Brake System ("VNBS")
On October 30, 2019, Veoneer signed definitive agreements to sell its 51% ownership in Veoneer Nissin Brake Japan ("VNBJ") and Veoneer Nissin Brake China ("VNBZ") entities that comprise VNBS to its joint venture partner Nissin-Kogyo Co., Ltd. (“Nissin Kogyo”), and Honda Motor Co., Ltd. The aggregate purchase price was $176 million. The divestiture of VNBJ and VNBZ was structured as two separate transactions each of which was completed on February 3, 2020, and the VNBS joint venture was terminated. See Note 4 "Divestiture and held for sale" for additional information.

Assets held for sale Veoneer Brake Systems ("VBS")
Following the strategic review initially launched in April 2019, in March 2020, Veoneer decided to focus on its core Electronics business and exit the brake control business. See Note 4 "Divestiture and held for sale" for additional information.

9


Note 2. Summary of Significant Accounting Policies
A summary of significant accounting policies is included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 21, 2020.
Other Income, Net
On March 30, 2020, Veoneer commenced arbitration against Nissin Kogyo regarding a dispute arising out of a Share Purchase Agreement (“SPA”) dated September 2015. On June 30, 2020, Veoneer agreed to settle the proceedings, along with any and all legal claims arising out of or relating to the SPA dispute, for $20 million. The cash settlement was received by the Company on June 30, 2020 and is reported among Other income, net in the unaudited Condensed Consolidated Statements of Operations.
Research, development and engineering
In early 2019, as a result of multiple factors, including general market conditions, numerous customer change requests, and challenges involved in developing new technologies for various customer programs, Veoneer launched a broad initiative to have its customers contribute more to the cost of developing these programs. The Company began to approach customers to negotiate or renegotiate new or existing agreements to provide for more favorable cost sharing terms. As part of this initiative, Veoneer approached a certain customer to adjust the terms of existing award agreements. On May 20, 2020 the Company entered into an adjustment agreement with such customer and received a lump sum settlement of $65 million for past research, development and engineering costs and implementation of change requests, and $11 million for software specific future development.
During the second quarter of 2020 the Company received a total of $76 million from the adjustment agreement. According to the Company’s accounting policies, research, development and most engineering expenses are expensed as incurred. These expenses are reported net of expense reimbursements from contracts to further customize existing products for specific customers.
For the six months ended June 30, 2020, the Company recognized a total reimbursement from customers of $81 million for past completed engineering services as a reduction of research, development and engineering costs on the unaudited Condensed Consolidated Statement of Operations.
In addition, as of June 30, 2020 the Company recognized $16 million from the adjustment agreement as deferred income reported among Other current liabilities in the unaudited Condensed Consolidated Balance Sheet. The deferred amount will be recognized in a systematic way and in proportion to the completion of the future engineering services related to the adjustment agreement as reimbursement from customers.
Accounting for credit losses
The Company has evaluated the available adoption options of common credit loss methods that are acceptable as per FASB Accounting Standards Codification Topic 326, Credit Losses. The Company adopted the available Loss-rate method where the impairment is calculated using an estimated loss rate and multiplying it by the asset’s amortized cost at the balance sheet date. This method appropriately reflects the Company´s risk pattern in relation to its accounts receivables.
The key components of the Company’s Loss-rate model are as follows:
A list of the Company's customers credit rating and credit default risk rate from Bloomberg.
Actual write-offs or reversals of previous write-offs of accounts receivables.
Evaluation of other unusual facts and circumstances which could impact the credit loss rate, such as risk of bankruptcy or potential collectability issues.
The Company’s credit loss model includes the Company’s customer list. The customer list captures the existing customers. The list is put into a Bloomberg data query to generate customers short-term credit rating. The credit default risk rate is used to calculate the credit loss rate or estimated loss rate.
For customers that do not have credit default risk rate, management uses the six-month LIBOR rate as a credit rating and a credit default risk rate. Management believes that the six-month LIBOR rate adequately reflects the short-term nature of the Company’s trade receivables and is also in line with the Company’s invoice payment terms.
10


Concentration of Credit Risk
A substantial majority of the Company’s trade receivables are derived from sales to OEMs. For the three and six months ended June 30, 2020 the Company’s four largest customers accounted for 55% and 59% of net sales, respectively and for the three and six months ended June 30, 2019, the Company’s four largest customers accounted for 60% and 59% of net sales, respectively. Additionally, as of June 30, 2020 and December 31, 2019, these four largest customers accounted for 40% and 39%, respectively, of the Company’s accounts receivables. The Company believes that the receivable balances from these largest customers do not represent a significant credit risk based on past collection experience. The Company has adopted credit policies and standards intended to accommodate industry growth and inherent risk. The Company believes that credit risks are moderated by the financial stability of the Company’s major customers.
New Accounting Standards
Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates (“ASUs”) to the FASB’s Accounting Standards Codification.
The Company considers the applicability and impact of all ASUs. ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company’s condensed consolidated financial statements.
Adoption of New Accounting Standards
In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments, which requires measurement and recognition of expected credit losses for financial assets held and requires enhanced disclosures regarding significant estimates and judgments used in estimating credit losses. ASU 2016-13 is effective for public business entities for annual periods beginning after December 15, 2019, and earlier adoption is permitted for annual periods beginning after December 15, 2018. The Company adopted ASU 2016-13 effective January 1, 2020 and applied a loss rate model to compute the expected credit loss allowance. The adoption of ASU 2016-13 did not have a material impact on the Company's condensed consolidated financial statements.
In November 2018, the FASB issued ASU 2018-18 Collaborative Arrangements (Topic 808), Clarifying the Interaction between Topic 808 and Topic 606, which (1) clarifies that certain transactions between collaborative arrangement participants should be accounted for under ASC Topic 606, Revenue from Contracts with Customers (Topic 606), when the collaborative arrangement participant is a customer in the context of a unit of account, (2) adds unit-of-account guidance in Topic 808 to align with Topic 606 when an entity is assessing whether the collaborative arrangement, or a part of the arrangement, is within the scope of Topic 606, (3) precludes presenting transactions together with revenue when those transactions involve collaborative arrangement participants that are not directly related to third parties and are not customers. The Company is required to adopt ASU 2018-18 in the first quarter of 2020. The adoption of ASU 2018-18 did not have a material impact on the Company's condensed consolidated financial statements.
In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement. ASU 2018-13 removes the requirement to disclose: the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. ASU 2018-13 requires disclosure of changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted. The Company is required to adopt ASU 2018-18 in the first quarter of 2020. The adoption of ASU 2018-13 did not have a material impact on the Company's condensed consolidated financial statements.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), to increase transparency and comparability among organizations by recognizing lease liabilities on the balance sheet and disclosing key information about leasing arrangements. ASU 2016-02 affects any entity that enters into a lease, with some specified scope exceptions. For public business entities, the amendments in ASU 2016-02 are effective for annual periods beginning after December 15, 2018, and interim periods within those annual periods. The Company adopted ASU 2016-02 in the annual period beginning January 1, 2019. The Company applied the modified retrospective transition method and elected the transition option to use the effective date January 1, 2019,
11


as the date of initial application. The Company did not adjust its comparative period financial statements for effects of ASU 2016-02, and has not made the new required lease disclosures for periods before the effective date. The Company has recognized its cumulative effect transition adjustment as of the effective date. In addition, the Company has elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, have allowed the Company to carry forward the historical lease classification. The adoption of the new standard resulted in recording operating lease assets and lease liabilities of approximately $75 million as of January 1, 2019. The adoption of the new lease standard did not have a material impact on the Company's condensed consolidated financial statements.
Accounting Standards Issued But Not Yet Adopted
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes. ASU 2019-12 is effective for public business entities for annual periods beginning after December 15, 2020, and early adoption is permitted. The amendments related to changes in ownership of foreign equity method investments or foreign subsidiaries should be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The Company plans to adopt ASU 2019-12 as of January 1, 2021. The Company has concluded that the pending adoption of ASU 2019-12 will not have a material impact on the Company’s condensed consolidated financial statements.
In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Topic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans. ASU 2018-14 modifies the disclosure requirements for employers that sponsor defined benefit pension or other post-retirement plans. ASU 2018-14 removes the requirements to disclose: amounts in accumulated other comprehensive income (loss) expected to be recognized as components of net periodic benefit cost over the next fiscal year; the amount and timing of plan assets expected to be returned to the employer; and the effects of a one-percentage point change in assumed health care cost trend rates. ASU 2018-14 requires disclosure of an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted for all entities and the amendments in this update are required to be applied on a retrospective basis to all periods presented. The Company is currently evaluating this guidance to determine the impact on the Company's condensed consolidated financial statements.
Note 3. Revenue
Disaggregation of revenue
In the following tables, revenue is disaggregated by primary region and products.
Net Sales by Region
Three Months Ended June 30, 2020 Three Months Ended June 30, 2019
(Dollars in millions) Electronics Brake Systems Total Electronics Brake Systems Total
Asia $ 59    $ —    $ 59    $ 89    $ 81    $ 170   
Americas 43      48    145    15    160   
Europe 77    —    77    159    —    159   
Total net sales $ 179    $   $ 184    $ 393    $ 96    $ 489   

Net Sales by Region
Six Months Ended June 30, 2020 Six Months Ended June 30, 2019
(Dollars in millions) Electronics Brake Systems Total Electronics Brake Systems Total
Asia $ 117    $ 24    $ 141    $ 179    $ 153    $ 332   
Americas 160    19    179    299    31    330   
Europe 226    —    226    322    —    322   
Total net sales $ 503    $ 43    $ 546    $ 800    $ 184    $ 984   

12


Net Sales by Products
Three Months Ended June 30, 2020 Three Months Ended June 30, 2019
(Dollars in millions) Electronics Brake Systems Total Electronics Brake Systems Total
Restraint Control Systems $ 100    $ —    $ 100    $ 209    $ —    $ 209   
Active Safety products 79    —    79    184    —    184   
Brake Systems —        —    96    96   
Total net sales $ 179    $   $ 184    $ 393    $ 96    $ 489   

Net Sales by Products
Six Months Ended June 30, 2020 Six Months Ended June 30, 2019
(Dollars in millions) Electronics Brake Systems Total Electronics Brake Systems Total
Restraint Control Systems $ 262    $ —    $ 262    $ 425    $ —    $ 425   
Active Safety products 241    —    241    375    —    375   
Brake Systems —    43    43    —    184    184   
Total net sales $ 503    $ 43    $ 546    $ 800    $ 184    $ 984   

Note 4. Divestiture and held for sale
VBS
In 2019, the Company started exploring strategic options for its non-core business in the Brake Systems segment. In the first quarter of 2020, management committed and approved a plan to sell VBS. The Company expects to sell the business within one year from management's approval of the plan. The business and its associated assets and liabilities meet the criteria for presentation as held for sale as of June 30, 2020 and were required to be adjusted to the lower of fair value less cost to sell or carrying value. This resulted in an impairment charge of approximately $144 million which was recorded within Gain/(loss) on divestiture and assets held for sales, net on the unaudited Condensed Consolidated Statements of Operations during the period ended June 30, 2020. The impairment was measured using third party sales pricing to determine fair values of the assets. The inputs utilized in the analyses are classified as Level 3 inputs within the fair value hierarchy as defined in ASC 820, "Fair Value Measurement." The assets and liabilities associated with the transaction are separately classified as held for sale in the unaudited Condensed Consolidated Balance Sheet as of June 30, 2020 and depreciation of long-lived assets ceased on June 30, 2020. The planned divestiture did not meet the criteria for presentation as a discontinued operation.
The major classes of assets and liabilities held for sale were as follows:
(Dollars in millions) As of
Assets held for sale June 30, 2020
Prepaid exp/accrued income $  
Property, plant and equipment, net 79   
Current deferred charges 81   
Impairment of carrying value (144)  
Total assets held for sale $ 17   
Liabilities held for sale
Accounts payable (6)  
Total liabilities held for sale $ (6)  

13


VNBS
In the fourth quarter of 2019, management approved a plan to sell VNBS. The business and its associated assets and liabilities met the criteria for presentation as held for sale as of December 31, 2019, and depreciation of long-lived assets ceased. The divestiture did not meet the criteria for presentation as a discontinued operation.
On October 30, 2019, the Company entered into definitive agreements with Nissin-Kogyo Co., Ltd. and Honda Motor Co., Ltd to divest VNBS. On February 3, 2020, the Company completed the sale of VNBS. The aggregate purchase price of the transaction was $176 million, subject to certain adjustments. The net cash proceeds after adjusting for closing costs was $175 million. The Company recognized a gain on the divestiture of $77 million, net of closing costs.
The major classes of assets and liabilities held for sale were as follows:
(Dollars in millions) As of
Assets held for sale December 31, 2019
Cash and cash equivalents $ 35   
Receivables, net 58   
Inventories, net 17   
Property, plant and equipment, net 126   
Intangible assets, net 66   
Other current assets 15   
Total assets held for sale $ 317   
Liabilities held for sale
Accounts payable 50   
Accrued expenses 20   
Related party short-term debt 12   
Pension liability  
Other current liabilities 28   
Total liabilities held for sale $ 118   

Note 5. Debt
The Company’s short and long-term debt consists of the following:
As of
(Dollars in millions) June 30, 2020 December 31, 2019
Short-Term Debt:
Short-term borrowings $ 20    $  
Long-Term Debt:
4.00% Convertible Senior Notes due 2024 (Carrying value) 165    160   
Other long-term borrowings    
Total Debt $ 191    $ 171   
Short-Term Debt:
On April 24, 2020, a wholly-owned subsidiary of the Company entered into a credit agreement with a customer pursuant to which it was entitled to borrow an aggregate amount of up to $17 million in the form of term loans. On June 25, 2020, the parties amended the credit agreement to extend the repayment period and to increase the aggregate amount available for borrowing to $26 million. The proceeds of any such term loans may only be used to fund costs and expenses incurred by the subsidiary for such customer’s projects. Obligations incurred under the credit agreement are guaranteed by the Company. As of June 30, 2020 the outstanding loan balance was $17 million and is included in Other current liabilities in the unaudited Condensed Consolidated Balance Sheet.
14


Long-Term Debt:
4.00% Convertible Senior Notes
On May 28, 2019, the Company issued, in a registered public offering in the U.S., Convertible Senior Notes (the “Notes”) with an aggregate principal amount of $207 million. The Notes bear interest at a rate of 4.00% per year payable semi-annually in arrears on June 1 and December 1 of each year, beginning December 1, 2019. The Notes will mature on June 1, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date.
The net proceeds from the offering of the Notes were approximately $200 million, after deducting issuance costs of $7 million. The Company accounted for these issuance costs as a direct deduction from the carrying amount of the Notes. These costs are being amortized into interest expense for 5 years or through June 2024.
The conversion rate is 44.8179 shares of common stock per $1,000 principal amount of Notes (equivalent to an initial conversion price of approximately $22.3125 per share of common stock). The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or if the Company deliver a notice of redemption, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Notes in connection with such a corporate event or notice of redemption, as the case may be. In no event will the conversion rate per $1,000 principal amount of notes as a result of this adjustment exceed 57.1428 shares of common stock, as stipulated in the indenture.
The Company may not redeem the Notes prior to June 1, 2022. On or after this date, the Company may redeem for cash, shares or both all or any portion of the Notes, at our option, if the last reported sale price of the Company's common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Notes.
If the Company undergoes a fundamental change (as defined in the indenture), holders may require the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.
The Notes are the Company's general unsecured obligations and rank senior in right of payment to all of the Company's indebtedness that is expressly subordinated in right of payment to the Notes, equal in right of payment with all of the Company's liabilities that are not so subordinated, effectively junior to any of the Company's secured indebtedness to the extent of the value of the assets securing such indebtedness, and structurally junior to all indebtedness and other liabilities (including trade payables) of our subsidiaries.
Holders may convert their Notes at their option at any time prior to the close of business on the business day immediately preceding March 1, 2024 only under the following circumstances: (1) if the last reported sale price of the Company's common stock for at least 20 trading days, whether or not consecutive, during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the "trading price" (as defined in the indenture) per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (3) if the Company calls any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events.
On or after March 1, 2024 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock, at the Company's election, as stipulated in the indenture.
In accounting for the issuance of the Notes, the Company separated the Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of a similar liability that does not have an associated convertible feature. The carrying amount of the equity component, representing the conversion option, which does not meet the criteria for separate accounting as a derivative as it is indexed to the Company's own stock, was determined by deducting the fair value of the liability component from the par value of the Notes. The difference between the principal amount
15


of the Notes and the liability component represents the debt discount, which is recorded as a direct deduction from the related debt liability in the unaudited Consolidated Condensed Balance Sheet and amortized to interest expense using the effective interest method over the term of the Notes. The effective interest rate on the Notes is 10%. The equity component of the Notes of approximately $46 million is included in additional paid-in capital in the unaudited Condensed Consolidated Balance Sheet and is not remeasured as long as it continues to meet the conditions for equity classification. The Company allocated transaction costs related to the Notes using the same proportions as the proceeds from the Notes. Transaction costs attributable to the liability component were recorded as a direct deduction from the related debt liability in the unaudited Condensed Consolidated Balance Sheet and amortized to interest expense over the term of the Notes, and transaction costs attributable to the equity component were netted with the equity component in shareholders’ equity.
The following table presents the outstanding principal amount and carrying value of the Notes:
 4.00% Convertible Senior Notes due 2024
As of
(Dollars in millions) June 30, 2020 December 31, 2019
Principal amount (face value) $ 207    $ 207   
Unamortized issuance cost (4)   (5)  
Unamortized debt discount (38)   (42)  
Net Carrying value $ 165    $ 160   
The Company recognized total interest expense related to the Notes of $4 million and $1 million for three months ended June 30, 2020 and 2019, respectively, and $8 million and $1 million for the six months ended June 30, 2020 and 2019, respectively, in the unaudited Condensed Consolidated Statements of Operations.
The estimated fair value of the Notes was $174 million as of June 30, 2020. The estimated fair value of the Notes was determined through consideration of quoted market prices. The fair value is classified as Level 2, as defined in Note 6 "Fair Value Measurements".
Note 6. Fair Value Measurements
The Company uses a three-level fair value hierarchy that categorizes assets and liabilities measured at fair value based on the observability of the inputs utilized in the valuation. The fair value hierarchy gives the highest priority to the quoted prices in active markets for identical assets and liabilities and lowest priority to unobservable inputs.
Level 1 - Financial assets and liabilities whose values are based on unadjusted quoted market prices for identical assets and liabilities in an active market that the Company has the ability to access.
Level 2 - Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable for substantially the full term of the asset or liability.
Level 3 - Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement.
Assets which are valued at net asset value per share ("NAV"), or its equivalent, as a practical expedient are reported outside the fair value hierarchy, but are included in the total assets for reporting and reconciliation purposes.
Items Measured at Fair Value on a Recurring Basis
Derivative instruments - The Company uses derivative financial instruments, “derivatives”, to mitigate the market risk that occurs from its exposure to changes in interest and foreign exchange rates. The Company does not enter into derivatives for trading or other speculative purposes. The Company’s use of derivatives is in accordance with the strategies contained in the Company’s overall financial risk policy. The derivatives outstanding as of June 30, 2020 were foreign exchange swaps. All swaps principally match the terms and maturity of the underlying obligation and no swaps have a maturity beyond six months. All derivatives are recognized in the unaudited condensed consolidated financial statements at fair value. Certain derivatives are from time to time designated either as fair value hedges or cash flow hedges in line with the hedge accounting criteria. For certain other derivatives hedge accounting is not applied either because non-hedge accounting treatment creates the same accounting result or the hedge does not meet the hedge accounting requirements, although entered into applying the same rationale concerning mitigating market risk that occurs from changes in interest and foreign exchange rates. The Company’s derivatives are classified as Level 2 of the fair value hierarchy and there were no transfers between the levels during this or comparable periods.
16


Financial Statement Presentation
The Company enters into master netting agreements, International Swaps and Derivatives Association (ISDA) agreements with all derivative counterparties. The netting agreements allow for netting of exposures in the event of default or breach of the counterparty agreement. The fair values in the Condensed Consolidated Balance Sheets have been presented on a gross basis. Derivative financial instruments designated and non-designated as hedging instruments are included in the Company’s Condensed Consolidated Balance Sheets. The notional value of the derivatives not designated as hedging instruments was $177 million as of June 30, 2020 and $291 million as of December 31, 2019. As of June 30, 2020, the derivatives not designated as hedging instruments was an asset of $1 million, and as of December 31, 2019, the derivatives not designated as hedging instruments was a liability of $1 million.
Gains and losses on derivative financial instruments recognized in the unaudited Condensed Consolidated Statements of Operations for the three months ended June 30, 2020 and 2019 were a loss of less than $1 million and a gain of less than $1 million, respectively, and for the six months ended June 30, 2020 and 2019 were a gain of $2 million and a gain of $1 million, respectively.
Items Measured at Fair Value on a Non-Recurring Basis
Certain assets and liabilities are measured at fair value on a nonrecurring basis. The fair value measurements are generally determined using unobservable inputs and are classified within Level 3 of the fair value hierarchy. These assets include long-lived assets, intangible assets and investments in affiliates, which may be written down to fair value as a result of impairment. The Company has determined that the fair value measurements included in each of these assets and liabilities rely primarily on Company-specific inputs and the Company’s assumptions about the use of the assets and settlements of liabilities, as observable inputs are not available. The Company has determined that each of these fair value measurements reside within Level 3 of the fair value hierarchy. To determine the fair value of long-lived assets, the Company utilizes the projected cash flows expected to be generated by the long-lived assets, then discounts the future cash flows over the expected life of the long-lived assets. VBS assets and liabilities classified as held for sale and the related impairment were measured using third party sales pricing to determine fair values of the assets. See Note 4 "Divestiture and held for sale" for additional information.
Investments
The Company may, as a practical expedient, estimate the fair value of certain investments using NAV of the investment as of the reporting date. This practical expedient generally deals with investments that permit an investor to redeem its investment directly with, or receive distributions from, the investee at times specified in the investee’s governing documents. Examples of these investments (often referred to as alternative investments) may include ownership interests in real assets, certain credit strategies, and hedging and diversifying strategies. They are commonly in the form of limited partnership interests. The Company uses NAV as a practical expedient when valuing investments in alternative asset classes and funds which are a limited partnership or similar investment vehicle.
On June 30, 2017, Veoneer committed to make a $15 million investment in Autotech Fund I, L.P. pursuant to a limited partnership agreement, and as a limited partner, periodically makes capital contributions toward this total commitment amount. As of June 30, 2020 and December 31, 2019, Veoneer contributed approximately $12 million and $10 million, respectively, to the investment in Autotech Fund I, L.P. For the period ended June 30, 2020 the Company has received distributions of $3 million from the partnership.
The carrying amounts of $9 million reflected in the unaudited Condensed Consolidated Balance Sheet in Investments for AutoTech Fund I, L.P approximates its fair value as of March 31, 2020 as this is the most recent information available to the Company at this time.
Note 7. Income Taxes
The income expense for three and six month periods ended June 30, 2020 was $2 million and $26 million, respectively. The income tax benefit for the three and six month periods ended June 30, 2019 was $10 million and $4 million, respectively. Discrete items, net were a benefit of $1 million and expense of $20 million for the three and six month periods ended June 30, 2020, respectively, and a benefit of $8 million and $5 million for the three and six month periods ended June 30, 2019, respectively. The discrete item in the six month period ended June 30, 2020 was primarily related to the tax impact of the divestiture of VNBS. Veoneer's effective tax rate differs from an expected statutory rate primarily due to the discrete item and losses in certain jurisdictions that are not benefited.
17


Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company assesses all available evidence, both positive and negative, to determine the amount of any required valuation allowance. Valuation allowances have been established for the Company’s operations in United States, Sweden, France, Japan and China.
Note 8. Inventories
Inventories are stated at the lower of cost (according to first-in-first-out basis, "FIFO") and net realizable value. The components of inventories were as follows:
As of
(Dollars in millions) June 30, 2020 December 31, 2019
Raw materials $ 99    $ 99   
Work in progress    
Finished products 51    62   
Inventories 159    169   
Inventory valuation reserve (27)   (25)  
Total inventories, net of reserve $ 132    $ 144   

Note 9. Equity Method Investment
As of June 30, 2020, the Company had one equity method investment, which is Zenuity, a 50% ownership joint venture with Volvo Cars.
During the second quarter of 2020, Veoneer contributed SEK 90 million (approximately $9 million) in cash (representing 50% of the total contribution, with the remainder made by Volvo Cars) into Zenuity to support its current operating cash flow needs.
During the first quarter of 2020, Veoneer contributed SEK 150 million (approximately $16 million) in cash (representing 50% of the total contribution, with the remainder made by Volvo Cars) into Zenuity to support its future operating cash flow needs.
The profit and loss attributed to the investment is shown in the line item Loss from equity method investment in the Unaudited Condensed Consolidated Statements of Operations. Veoneer’s share of Zenuity’s loss for the three and six month periods ended June 30, 2020 was $19 million and $38 million, respectively. Veoneer's share of Zenuity's loss for the three and six month periods ended June 30, 2019 was $18 million and $35 million, respectively. As of June 30, 2020 and December 31, 2019, the Company’s equity investment in Zenuity was $74 million and $87 million, respectively.
Certain unaudited summarized income statement information of Zenuity, for the three and six month periods ended June 30, 2020 and 2019, is shown below:
Three Months Ended June 30 Six Months Ended June 30
(Dollars in millions) 2020 2019 2020 2019
Net sales $   $ —    $   $  
Gross profit —    —    —    —   
Operating loss (39)   (35)   (75)   (69)  
Loss before income taxes (39)   (35)   (75)   (69)  
Net loss (39)   (36)   (75)   (69)  

18


Note 10. Accrued Expenses
  As of
(Dollars in millions) June 30, 2020 December 31, 2019
Operating related accruals $ 69    $ 43   
Employee related accruals 72    76   
Customer pricing accruals 23    39   
Product related liabilities1
18    15   
Other accruals 18    19   
Total Accrued Expenses $ 200    $ 192   
1 As of June 30, 2020 and December 31, 2019, $11 million and $8 million, respectively, of product related liabilities were indemnifiable losses subject to indemnification by Autoliv and an indemnification asset is included in Other current assets.
Note 11. Retirement Plans
Defined Benefit Pension Plans
The Company’s net periodic benefit costs for plans for the three and six months ended June 30, 2020 and 2019 were as follows:
  Three Months Ended June 30 Six Months Ended June 30
(Dollars in millions) 2020 2019 2020 2019
Service cost $   $   $   $  
Interest cost   —       
Expected return on plan assets (1)   (1)   (1)   (1)  
Net periodic benefit cost $   $ —    $   $  
The service cost and amortization of prior service cost components are reported among employee compensation costs in the unaudited Condensed Consolidated Statements of Operations. The remaining components (interest cost, expected return on plan assets and amortization of actuarial loss) are reported in Other non-operating items, net in the unaudited Condensed Consolidated Statements of Operations.
Note 12. Stock Incentive Plan
The Veoneer, Inc. 2018 Stock Incentive Plan was established and effective on June 29, 2018 to govern the Company’s stock-based awards that will be granted in the future. The Veoneer, Inc. 2018 Stock Incentive Plan authorizes the grant of 3 million shares of Veoneer common stock for future equity awards to Veoneer employees and non-employee directors and authorizes up to 1.5 million additional shares to be used for the conversion of outstanding Autoliv stock awards in connection with the Spin-Off. Approximately 1 million shares were used for the conversion of the outstanding grants.
During the six months ended June 30, 2020 under the Company’s long-term incentive (LTI) program, certain employees and non-employee directors received restricted stock units (RSUs) without dividend equivalent rights and performance shares (PSs) without dividend equivalent rights. The allocation between RSUs and PSs was 747,466 RSUs and 415,381 PSs at 100% target.
The majority of the RSUs granted will vest on the third anniversary of the grant date, subject to the grantee’s continued employment with the Company on the vesting date and acceleration of vesting in certain circumstances. The fair value of RSUs and PSs granted in 2020 were calculated by using the closing stock price on the grant dates. The grant date fair value for the RSUs and PSs, granted in 2020 was $11 million.
PSs granted in 2020 will earn out during the first quarter of 2023, upon the Compensation Committee’s certification of achievement of the applicable performance goals. The grantee may earn 0%-200% of the target number of PSs based on the Company’s achievement of specified targets. The performance target is the Company’s gross margin for the applicable performance period. Each PS represents a promise to transfer a share of the Company’s common stock to the employee following completion of the performance period, provided that the performance goals mentioned above are met and provided, further, that the grantee remains employed through the performance period, subject to certain limited exceptions.
19


Veoneer recognized total stock (RSUs PSs and Stock Options) compensation cost of $2 million and $4 million for the three and six month periods ended June 30, 2020, respectively. During the three and six month periods ended June 30, 2019, the Company recorded $2 million and $3 million, respectively.
Note 13. Contingent Liabilities
Legal Proceedings
Various claims, lawsuits and proceedings are pending or threatened against the Company, covering a range of matters that arise in the ordinary course of its business activities with respect to commercial, product liability and other matters. Litigation is subject to many uncertainties, and the outcome of any litigation cannot be assured. After discussions with counsel, it is the opinion of management that the various legal proceedings and investigations to which the Company currently is a party will not have a material adverse impact on the condensed consolidated financial position of Veoneer, but the Company cannot provide assurance that Veoneer will not experience material litigation, product liability or other losses in the future.
Product Warranty, Recalls, and Intellectual Property
Veoneer is exposed to various claims for damages and compensation if its products fail to perform as expected. Such claims can be made, and result in costs and other losses to the Company, even where the product is eventually found to have functioned properly. Where a product (actually or allegedly) fails to perform as expected or is defective, the Company may face warranty and recall claims. Where such (actual or alleged) failure or defect results, or is alleged to result, in bodily injury and/or property damage, the Company may also face product liability and other claims. There can be no assurance that the Company will not experience material warranty, recall or product (or other) liability claims or losses in the future, or that the Company will not incur significant costs to defend against such claims. The Company may be required to participate in a recall involving its products. Each vehicle manufacturer has its own practices regarding product recalls and other product liability actions relating to its suppliers. As suppliers become more integrally involved in the vehicle design process and assume more of the vehicle assembly functions, vehicle manufacturers are increasingly looking to their suppliers for contribution when faced with recalls and product liability claims. Government safety regulators may also play a role in warranty and recall practices. A warranty, recall or product-liability claim brought against the Company in excess of its insurance may have a material adverse effect on the Company’s business. Vehicle manufacturers are also increasingly requiring their outside suppliers to guarantee or warrant their products and bear the costs of repair and replacement of such products under new vehicle warranties. A vehicle manufacturer may attempt to hold the Company responsible for some, or all, of the repair or replacement costs of products when the product supplied did not perform as represented by the Company or expected by the customer. Accordingly, the future costs of warranty claims by the customers may be material. However, the Company believes its established reserves are adequate. Veoneer’s warranty reserves are based upon the Company’s best estimates of amounts necessary to settle future and existing claims. The Company regularly evaluates the adequacy of these reserves, and adjusts them when appropriate. However, the final amounts actually due related to these matters could differ materially from the Company’s recorded estimates.
In addition, as vehicle manufacturers increasingly use global platforms and procedures, quality performance evaluations are also conducted on a global basis. Any one or more quality, warranty or other recall issue(s) (including those affecting few units and/or having a small financial impact) may cause a vehicle manufacturer to implement measures such as a temporary or prolonged suspension of new orders, which may have a material impact on the Company’s results of operations.
The Company carries insurance for potential recall and product liability claims at coverage levels based on the Company’s prior claims experience. Veoneer cannot assure that the level of coverage will be sufficient to cover every possible claim that can arise in the Company’s businesses, now or in the future, or that such coverage always will be available should the Company, now or in the future, wish to extend, increase or otherwise adjust the Company’s insurance.
In its products, the Company utilizes technologies which may be subject to intellectual property rights of third parties. While the Company does seek to procure the necessary rights to utilize intellectual property rights associated with its products, it may fail to do so. Where the Company so fails, the Company may be exposed to material claims from the owners of such rights. Where the Company has sold products which infringe upon such rights, its customers may be entitled to be indemnified by the Company for the claims they suffer as a result thereof. Such claims could be material.
20


Product Related Liabilities
The Company records liabilities for product related risks when probable claims are identified and when it is possible to reasonably estimate costs. Provisions for warranty claims are estimated based on prior experience, likely changes in performance of newer products, and volume of the products sold. The provisions are recorded on an accrual basis.
The table below summarizes the change in product related liabilities in the unaudited Condensed Consolidated Balance Sheets.
  Three Months Ended June 30 Six Months Ended June 30
(Dollars in millions) 2020 2019 2020 2019
Reserve at beginning of the period $ 18    $ 14    $ 15    $ 16   
Change in reserve        
Cash payments (1)   (1)   (3)   (3)  
Reserve at end of the period $ 18    $ 14    $ 18    $ 14   
For the three and six month periods ended June 30, 2020 and June 30, 2019, cash paid primarily relate to warranty related issues. The increase in the reserve balance as of June 30, 2020 compared to the prior year was due to a recall related reserve liability. Agreements entered into between Autoliv and Veoneer in connection with the Spin-Off provide for Autoliv to indemnify Veoneer for certain liabilities related to electronics products manufactured before April 1, 2018. As of June 30, 2020 and December 31, 2019, $11 million and $8 million, respectively, of product related liabilities were indemnifiable losses subject to indemnification by Autoliv and an indemnification asset is included in Other current assets.
Guarantees
The Company provided lease guarantees to Zenuity of $15 million and $7 million as of June 30, 2020, and December 31, 2019, respectively. These represent the maximum potential amount of future (undiscounted) payments that Veoneer could be required to make under the guarantees in the event of default by the guaranteed parties. These guarantees will generally cease upon expiration of current lease agreements between 2020 and 2022. There are no liabilities recorded in the unaudited Condensed Consolidated Balance Sheet as of June 30, 2020 and December 31, 2019 related to these guarantees.

21


Note 14. Loss per share
Basic loss per share is computed by dividing net loss for the period by the weighted average number of shares of common stock outstanding during the period. Diluted loss per share is computed by dividing net loss for the period by the weighted average number of shares of common stock and potentially dilutive common stock outstanding during the period. The dilutive effect of outstanding options and equity incentive awards is reflected in diluted loss per share by application of the treasury stock method. The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2020 and 2019.
Three Months Ended June 30 Six Months Ended June 30
(Dollars in millions, except per share amounts)  2020 2019 2020 2019
Numerator:    
Basic and diluted:    
Net loss attributable to Veoneer $ (90)   $ (133)   $ (322)   $ (270)  
Denominator:    
Basic: Weighted average number of shares outstanding (in millions) 111.58    96.06    111.52    91.68   
Diluted: Weighted-average number of shares outstanding, assuming dilution (in millions)1
111.58    96.06    111.52    91.68   
Basic loss per share $ (0.80)   $ (1.39)   $ (2.89)   $ (2.94)  
Diluted loss per share $ (0.80)   $ (1.39)   $ (2.89)   $ (2.94)  
1 Shares in the diluted loss per share calculation represent basic shares due to the net loss.
In periods when the Company has a net loss, equity incentive awards are excluded from the Company's calculation of earnings per share as their inclusion would have an antidilutive effect. The Company excluded equity incentive awards of 866,008 and 649,349 shares for the three and six month periods ended June 30, 2020, respectively, and 290,483 and 301,898 for the three and six month periods ended June 30, 2019, respectively, from the diluted loss per share calculations.
The Company may settle the conversions of the Notes in cash, shares of the Company's common stock or any combination thereof at its election. For the Notes, the number of shares of the Company's common stock issuable at the conversion price of $22.3125 per share would be 9,277,305 shares if the Company elected to settle the conversion wholly in shares. See Note 5 "Debt". Due to anti-dilutive effects, the Company excluded potential convertible shares due to the Notes of 9,277,305 for the three and six month periods ended June 30, 2020 and 3,364,297 and 1,691,442 for the three and six month periods ended June 30, 2019, respectively, from the diluted loss per share calculations.
Note 15. Segment Information
Financial results for the Company's reportable segments have been prepared using a management approach, which is consistent with the basis and manner in which financial information is evaluated by the Company's Chief Operating Decision Maker (CODM) in allocating resources and in assessing performance. The Company has two operating segments, Electronics and Brake Systems. Electronics includes all of electronics resources and expertise, restraint control systems and active safety products and Brake Systems provides brake control and actuation systems. The operating results of the operating segments are regularly reviewed by the Company’s CODM, the Chief Executive Officer, to assess the performance of the individual operating segments and to make decisions about resources to be allocated to the operating segments.
The accounting policies for the reportable segments are the same as those described in Note 2 "Summary of Significant Accounting Policies" included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 21, 2020.
22


Loss Before Income Taxes Three Months Ended June 30 Six Months Ended June 30
(Dollars in millions) 2020 2019 2020 2019
Electronics $ (29)   $ (101)   $ (123)   $ (191)  
Brake Systems (20)   (17)   (33)   (37)  
Segment operating loss (49)   (118)   (156)   (228)  
Corporate and other (15)   (19)   (30)   (37)  
Loss on divestiture and Assets held for sale —    —    (67)   —   
Interest and other non-operating items, net (5)     (4)    
Loss from equity method investment (19)   (18)   (38)   (35)  
Loss before income taxes $ (88)   $ (152)   $ (295)   $ (294)  

Note 16. Relationship with Former Parent and Related Entities
Transactions with Related Parties
Veoneer and Autoliv entered into a Transition Services Agreement ("TSA") under which certain services are provided by Autoliv to Veoneer and certain services are provided by Veoneer to Autoliv. The Company recognized less than $1 million of expense under the TSA for the three and six month periods ended June 30, 2020, and $1 million and $3 million of expense under the TSA for the three and six month periods ended June 30, 2019 respectively. The Company recognized less than $1 million of income under the TSA for the three and six month periods ended June 30, 2020 and 2019.
Throughout the periods covered by the unaudited condensed consolidated financial statements, Veoneer sold finished goods to Autoliv and Nissin Kogyo, the 49% owner in VNBS (a former 51% owned subsidiary). Related party sales amount to $11 million and $30 million for the three and six month periods ended June 30, 2020, respectively and $26 million and $52 million for the three and six month periods ended June 30, 2019, respectively.
Related Party Balances
Amounts due to and due from related parties are summarized in the below table:
Related Party As of
(Dollars in millions) June 30, 2020 December 31, 2019
Related party receivable $   $ 11   
Related party payables    
Related party short-term debt —     
Related party receivables are mainly driven by reseller agreements put in place in connection with the Spin-Off. The reseller agreements are between Autoliv and Veoneer and facilitate the temporary arrangement of the sale of Veoneer products manufactured for certain customers for a limited period after the Spin-Off. Autoliv will collect the customer payments and will remit the payments to Veoneer.
Note 17. Factoring
The Company receives bank notes generally maturing within six months from certain of its customers in China to settle trade accounts receivable. The Company may hold such bank notes until maturity, exchange them with suppliers to settle liabilities, or sell them to third party financial institutions in exchange for cash.
For the six months ended June 30, 2020 and 2019, the Company has entered into arrangements with financial institutions and sold $23 million and $36 million, respectively, of trade receivables without recourse and $6 million and $23 million, respectively, of bank notes without recourse, which qualify as sales as all rights to the trade and notes receivable have passed to the financial institution.
As of June 30, 2020, the Company has $2 million of trade notes receivables which remain outstanding and will mature within the third quarter of 2020. The collections of such bank notes are included in operating cash flows based on the substance of the underlying transactions, which are operating in nature.
23


Note 18. Subsequent Events
On April 2, the Company entered into a non-binding agreement with Volvo Cars to separate Zenuity, a 50% ownership joint venture with Volvo Cars in order for each company to more effectively drive their respective strategies. The parties entered into definitive agreements and effected the separation on July 1, 2020. As part of the split, Veoneer received IP licenses and added around 200 software engineers, located in Germany, the US and Sweden. The Company is evaluating the impact of the transaction and expects to recognize a gain, but is unable to reasonably estimate the amount of the gain at this time.

On April 24, 2020, a wholly-owned subsidiary of the Company entered into a credit agreement with a customer pursuant to which it was entitled to borrow an aggregate amount of up to $17 million in the form of term loans. On June 25, 2020, the parties amended the credit agreement to extend the repayment period and to increase the aggregate amount available for borrowing to $26 million. On July 2, 2020, the Company drew an additional $9 million in the form of a new term loan under the amended credit agreement. The proceeds of any such term loans may only be used to fund costs and expenses incurred by the subsidiary for such customer’s projects.
24


ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand the results of operations, financial condition and cash flows of Veoneer, Inc. (“Veoneer,” the “Company,” “we,” or “our”). This MD&A should be read in conjunction with the financial statements and accompanying notes to the financial statements included elsewhere herein, as well as the risk factors and other disclosures made in this Quarterly Report on Form 10-Q and in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 21, 2020.
Introduction
The following MD&A is intended to help you understand the business operations and financial condition of the Company. This MD&A is presented in the following sections:
Executive Overview
COVID-19 Commentary
2020 Outlook
Trends, Uncertainties and Opportunities
Market Overview
Results of Operations
Non-U.S. GAAP Financial Measures 
Liquidity and Capital Resources
Off-Balance Sheet Arrangements and Other Matters
Contractual Obligations and Commitments
Significant Accounting Policies and Critical Accounting Estimates
Veoneer is a Delaware corporation with its principal executive offices in Stockholm, Sweden. The Company functions as a holding corporation and owns two principal operating subsidiaries, Veoneer AB and Veoneer US, Inc. On June 29, 2018 the spin-off of Veoneer from Autoliv, Inc. ("Autoliv") was completed through the distribution by Autoliv of all the outstanding shares of common stock of Veoneer to Autoliv’s stockholders as of the close of business on June 12, 2018, the common stock record date for the distribution, in a tax-free, pro rata distribution (the "Spin-Off"). On July 2, 2018, the shares of Veoneer common stock commenced trading on the New York Stock Exchange under the symbol “VNE” and the Veoneer Swedish Depository Receipts representing shares of Veoneer common stock commenced trading on Nasdaq Stockholm under the symbol “VNE SDB.”
Veoneer is a global leader in the design, development, manufacture, and sale of automotive safety electronics with a focus on innovation, quality and manufacturing excellence. Prior to the Spin-Off, Veoneer operated for almost four years as an operating segment within Autoliv.  Veoneer's safety systems are designed to make driving safer and easier, more comfortable and convenient for the end consumer and to intervene before a collision to avoid a potentially hazardous situation. Veoneer endeavors to prevent vehicle accidents or reduce the severity of impact in the event a crash is unavoidable. Through our customer focus, and being an expert partner with our customers, we intend to develop human centric systems that benefit vehicle occupants.
Veoneer’s current product offerings include automotive radars, mono and stereo vision cameras, night vision systems, positioning systems, advanced driver assist systems ("ADAS") electronic control units, passive safety electronics (airbag control units and crash sensors), brake control systems and a complete ADAS software offering towards highly automated driving ("HAD") and eventually autonomous driving. In addition, we offer driver monitoring systems, LiDAR sensors, RoadScape positioning and other technologies critical for HAD and AD solutions by leveraging our partnership network and internally developed intellectual property.

25


Executive Overview
The second quarter was very unusual. The light vehicle production declined by around 45%, the worst decline in recorded history. The many complexities in terms of regional differences, global supply chains, short delivery notices and several other factors, made it a very difficult environment for running effective and efficient operations. The health of our employees remained a continued focus, not least because of the additional challenges of safely ramping up our operations, as the COVID -19 pandemic is first and foremost a health crisis. Despite the extreme conditions in the quarter, our market adjustment initiatives are having the desired effects and we are currently on track to reach our efficiency targets for 2020. In the first and second quarter we have been particularly successful in customer negotiations which were reflected in our results in the second quarter. We are also continuing to deliver on-going improvements in RD&E and other cost efficiencies according to plan.
During the quarter we continued the introduction of the next generation of our Active Safety portfolio. Our fourth-generation vision system is now launched and the indications are that this system is performing very well, further strengthening our position as a leading challenger in the vision market. There have now also been a total of eleven launches of our next generation 77GHz radar product, including two recent launches of forward looking radar, a very important development as we see this generation of our radar product as highly competitive in the market for years to come.
The trend, focus and commercial opportunity for the next decade is in collaborative driving and active safety. The finalization of the split of Zenuity and the integration of more than 200 talented software engineers into our systems and software team fits right into that opportunity. These additions are focused on driving policy, which complements the team mainly focused on perception software and system design. Having this combined capability fully in-house further enhances our ability to develop full systems as well as individual products for all different types of OEMs and segments of the light vehicle market. We are also encouraged by the initial positive reviews of the Polestar 2. Most of the Active Safety system on the Polestar 2, including the entire system ADAS software stack, is delivered by Veoneer, a good reference for the next steps for our systems and software business. Further launches are being rolled out in the second half of 2020 and beyond.
COVID-19 Commentary
The situation created by the COVID-19 pandemic has led to an unprecedented economic global uncertainty. This includes the automotive industry and light vehicle production ("LVP") for 2020 and the years ahead. We have been more conservative with our contingency planning assumptions than the July industry estimate from IHS which assumes a year-over-year decline of approximately 22%.
As noted in our 2020 Outlook, in response to the pandemic, the Company has additional market adjustment initiatives ("MAI") underway to mitigate the impact of the pandemic on its strong cash position. Veoneer estimates the organic sales (non-U.S. GAAP financial measure) impact from the lower customer demand to be approximately $190 million for the second quarter. This, in combination with the first quarter, implies the first half 2020 negative organic sales impact on Veoneer from the lower customer volumes was approximately $220 million.
The Company intends to continue to extend its MAI program (which includes efficiency programs, strategic reviews and portfolio optimization) to further mitigate the impact of the pandemic on its cash flow and operating results. This includes reducing its annual RD&E, net by more than $100 million and other expenses with the intention of reducing the Company's operating loss and conserving cash in 2020 so as to enter 2021 in a stable cash position.
During the latter part of the second quarter customers in Europe and North America gradually started to ramp up their production after the majority of their factories were shut down during the latter part of the first quarter continuing into the early part of the second quarter. The situation in China has stabilized and also the other Asian car producing countries are gradually returning to more normal production levels.
As our OEM customers return to production, we are returning to higher production levels as well, taking additional precautions to ensure the safety of our associates in each of our facilities, in accordance with detailed developed protocols. It is still uncertain how quickly our customers will ramp-up as production volumes may continue to fluctuate depending on underlying consumer demand.
In 2020, the most important driver for Veoneer’s business is new customer and technology launches. For the top 15 launches we see no cancellations of projects, however approximately half have been postponed by up to one quarter while the rest remain on track, or actually even slightly ahead of schedule. The exact volumes and consumer take rates are hard to predict at this point in time. The health and safety of our associates continues to be our first priority, and we are taking the necessary actions to protect our associates, safeguard our operations and meet our customers' needs while managing through these unprecedented circumstances.
26


2020 Outlook
Due to the market uncertainty that has been created by the COVID-19 pandemic it is becoming increasingly difficult to provide updated sales indications and specific organic sales for FY'20. We currently expect some launch delays during 2020, however the Company expects to out-perform the global LVP in 2020, assuming no major additional launch delays.
Veoneer continues to implement additional MAIs with the underlying goal to off-set the negative effects from lower sales and impact on cash flow. As a result of these actions, the Company's outlook remains unchanged where Veoneer expects cash flow before financing activities (non-U.S. GAAP financial measure) to be approximately $(200) million for the second half of 2020 and the operating loss to improve in 2020 as compared to 2019, on a comparable basis.
Veoneer expects RD&E, net in FY'20 to improve by more than $100 million as compared to 2019, on a comparable basis. Capital expenditures are now expected to be less than $125 million for FY'20.
Trends, Uncertainties and Opportunities
Trend toward Collaborative Driving
The environment around us continues to be rapidly changing and we currently see a shift across the automotive and autotech industries. The industry developments during 2019 have further strengthened the trend toward advanced driver support - Collaborative Driving - and away from fully autonomous cars for the consumer based vehicle mass market.
New technologies, creating new levels of interaction and driver support are starting to revolutionize driving, but we also see the driver being actively involved for many years to come. While the industry refers to “Level 2+” or even "Level 2++" Veoneer calls this Collaborative Driving, and includes any SAE level of automation. At the same time there is a growing realization that the introduction of truly self-driving cars will likely take longer and be more expensive than previously anticipated. This fundamental insight opens up new opportunities for companies, including Veoneer, but it also requires adjusting the priorities of resources. As such, we believe that the market will stay mainly focused on Level 1-Level 2+ autonomous driving solutions for the next decade however the recent developments of the COVID-19 pandemic, during the first half of 2020, and perhaps ongoing impact, could affect the evolution of ADAS, Collaborative Driving and AD for consumer purchased light vehicles.
Global Regulatory and Test Rating Developments
Europe continues to take a proactive role in promoting or requiring Active Safety technologies. The European New Car Assessment Program (“NCAP”) continuously updates its test rating program to include more active safety technologies to help the European Union reach its target of cutting road fatalities by 50% by 2030, as compared to 2020. In May 2020 Euro NCAP announced that is was postponing the roll-out of upcoming road map updates by one year (from 2022 to 2023 and from 2024 to 2025). This should help our industry to overcome the situation with respect to the COVID-19 pandemic, but it should not change the overall trend towards introduction of new roadmap requirements, which are just delayed by one year. We anticipate strong global sensor adoption rate increases (forward, side and rear) due to the European NCAP's push for crash avoidance, increased adoption rates due to growing demand around ADAS software features, volume growth due to redundant sensing concepts needed for higher levels of autonomy, potential opportunities in relation to compliance with cyber-security and software updates and step-by-step increased demand for connectivity components as a result.
One June 26, 2020, the UNECE’s World Forum for Harmonization of Vehicle Regulations, announced the first binding international regulation on “level 3” vehicle automation. The new regulation marks an important step towards the wider deployment of automated vehicles to help realize a vision of safer, more sustainable mobility for all. Starting in January 2021 the regulation provides guidelines on the Automated Lane Keep System ("ALKS") feature, requires driver availability recognition systems, and a "black box" data storage system for AD. It also outlines requirements for emergency and minimal risk maneuvers and driver transition demand as well as cyber-security and software update protocols.
On May 17, 2018, the European Commission proposed a new mandate, as part of the European General Safety Regulation ("GSR") road-map through 2028, to make certain Active Safety features compulsory in light vehicles by 2022. During March of 2019 the EU mandate was adopted as initially proposed by the European Commission. We believe that adoption of the mandate will significantly expand demand for our Active Safety products. Indeed, with respect to sensors and ADAS software features, our order intake since the adoption of the mandate seems to reflect the anticipated increase in demand. However, during 2019 we have seen OEM delays in the sourcing of these technologies as customers reconsider how they want to architect and design, in a scalable way to include these new standard technologies. In addition, we believe that the mandate and the European GSR generally will influence other market regulators as they evaluate their respective vehicle test rating programs and safety legislation.
27


In China, the Ministry of Industry and Information Technology issued the Key Working Points of Intelligent Connected Vehicle Standardization for 2018 to promote and facilitate the development of the intelligent connected vehicles industry, and advance the development of fundamental standards and those that are in urgent demand. The guideline has pointed out that more than 30 key standards will be defined by 2020 to fund the systems for ADAS and low-level autonomous driving, and a system of over 100 standards will be set up by 2025 for higher level autonomous driving. During the third quarter of 2018, the Chinese government commenced testing of new vehicles according to the new China New Car Assessment Program where active safety features like Autonomous Emergency Braking ("AEB") are required to achieve the maximum safety rating.
On October 4, 2018, the U.S. Department of Transportation ("DoT") issued new voluntary guidelines on automated driving systems ("ADS") under its “Preparing for the Future of Transportation: Automated Vehicles 3.0” initiative, building on its “Vision for Safety 2.0” from September 2017, which prioritized aligning federal guidance around twelve safety design elements of interest to the auto industry. This initiative should have a positive impact on the adoption of ADAS and HAD on the road towards Autonomous Vehicles ("AV"). On April 2, 2020 the U.S DoT closed the comment period for the “Automated Vehicles 4.0” which seeks to ensure a consistent U.S. Government approach to AV technologies, and to detail the authorities, research, and investments being made across the United States so that the United States can continue to lead AV technology research, development, and integration.
In 2018 the UN Economic Commission for Europe created a new Working Party to deal with regulations for Automated/Autonomous and Connected Vehicles. In addition to the EU and Japan, which have both started to work closely together to develop ADAS regulations, in the last three years, the U.S. and China have both indicated a willingness to be active in several working groups towards harmonization of future regulations for ADAS and AV. This would create a common umbrella for countries which follow type-approval rules (EU, Japan, Australia) and countries which are outside of type-approval system, e.g., under self-certification regimes (U.S., Korea) or specific national rules (China).
Key future potential regulations are expected for (i) safety critical ADAS-features (e.g. AEB); (ii) Highway AV-features (Physical Tests + Real World Test Drive + Audit); (iii) Cyber-security and Software updates; and (iv) Connected Vehicles. On one hand, the agreement on minimal common base requirements for the industry will take a longer time and therefore may postpone introduction of regulations. On the other hand, the harmonization with base requirements would help the industry while a more active position from China may help to pull forward some safety critical ADAS technologies which are not yet considered as relevant for regulation in EU and Japan (e.g. Blind Spot or Night Vision).
Market Overview
Millions (except where specified)
IHS as of July 16, 2020
Light Vehicle Production by Region - 2020
China Japan Rest of Asia Americas Europe Other Total
Second Quarter 2020 5.6    1.2    1.2    1.4    2.1    0.3    11.7   
Change vs. 2019 % (47) % (61) % (72) % (62) % (48) % (46) %
For the second quarter of 2020, global light vehicle production (according to IHS) declined by approximately 46% mainly due to the global outbreak of the COVID-19 pandemic. At the beginning of the quarter global LVP was expected to decline by approximately 45%. Major vehicle producing geographies impacted by the pandemic include: Europe (62)%, South Korea (24)%, North America (70)% and Japan (47)% while China increased 7%, as compared to 2019 for the second quarter..
Millions (except where specified)
IHS as of July 16, 2020
Light Vehicle Production by Region - 2020
China Japan Rest of Asia Americas Europe Other Total
Full Year 2020 20.1    7.1    8.5    13.8    15.8    1.5    66.8   
Change vs. 2019 (14) % (21) % (31) % (25) % (25) % (24) % (22) %
For the full year of 2020, global light vehicle production (according to IHS) is expected to decline by approximately 22%, due the anticipated full year effects of the COVID-19 pandemic. At the beginning of the quarter global LVP was expected to decline by approximately 21%. Every major vehicle producing geography is expected to be impacted by the pandemic including: China (14)%, Europe (25)%, South Korea (16)%, North America (23)% and Japan (21)%.
The expected decline of approximately 19 million light vehicles in 2020 as compared to 2019 is the highest light vehicle decline in a single year on record, and is the third consecutive annual decline in light vehicle production from 2017 when a record 92 million light vehicles were produced.
28


Results of Operations
Three Months Ended June 30, 2020 Compared to Three Months Ended June 30, 2019
The following analysis illustrates Veoneer’s overall and by segment performance for the three months ended June 30, 2020 and 2019 along with components of change compared to the prior year.
Net Sales by Product
The following tables illustrate Veoneer’s consolidated net sales by product for the three months ended June 30, 2020 and 2019 along with components of change compared to the prior year.
Net Sales Three Months Ended June 30 Components of Change vs. Prior Year
(Dollars in millions, except where specified) 2020 2019 US GAAP
Reported Change
Currency Divestiture
Organic1
$ $ $ % $ % $ % $ %
Restraint Control Systems 100    209    (109)   (52)   (4)   (2)   —    —    (105)   (50)  
Active Safety 79    184    (105)   (57)   (2)   (1)   —    —    (103)   (56)  
Brake Systems   96    (91)   (94)   —    —    (81)   (85)   (10)   (64)  
Total $ 184    $ 489    $ (305)   (62) % $ (6)   (1) % $ (81)   (17) % $ (218)   (53) %
1 Non-U.S. GAAP measure reconciliation for Organic Sales
Net Sales - Veoneer’s net sales for the quarter declined by 62% to $184 million as compared to 2019. Organic sales1 declined by 53% as compared to the 46% decline in LVP for the quarter. The remainder of the decline was from net currency translation effects of 1% and the Veoneer Nissin Brake Systems ("VNBS")-Asia (defined below) divestiture of 17%. During the quarter, organic sales developed in-line with our expectations from the beginning of the quarter.
Sequentially, from the first quarter in 2020 net sales decreased 49% or $178 million primarily due to the impact of COVID-19 in North America and Europe. The negative impact of COVID-19 on organic sales is estimated to be approximately $190 million during the second quarter.
Restraint Control Systems - Net sales for the quarter of $100 million decreased by 52% as compared to 2019. The organic sales decline of 50% was primarily due to the reduction in LVP driving lower production volumes in Europe and North America.
Active Safety - Net sales for the quarter of $79 million decreased by 57% as compared to 2019. This decline was primarily driven by the organic sales decline of 56%. This under-performance versus the LVP was driven by our higher content per vehicle ("CPV") on premium brands in North America and Europe, where the LVP declined 70% and 62%, respectively.
The COVID-19 impact on lower underlying LVP in our major markets for our Active Safety products more than offset the strong demand for mono, stereo and thermal camera systems and ADAS ECUs on several models.
Brake Systems - Net sales for the quarter of $5 million decreased by 94% as compared to 2019. The VNBS-Asia divestiture accounted for a 85% decline or $81 million while the remaining organic sales decline was $10 million or approximately 64%.
Electronics Segment Three Months Ended June 30 Components of Change vs. Prior Year
(Dollars in millions, except where specified) 2020 2019 US GAAP
Reported Change
Currency
Organic1
$ % $ % $ % $ % $ %
Net Sales 179    393    (214)   (55)   (6)   (2)   (208)   (53)  
Operating Loss / Margin (29)   (16.0)   (101)   (25.7)   72   
Segment EBITDA1 / Margin
(6)   (3.2)   (81)   (20.5)   75   
Associates 6,705    7,763    (1,058)  
1 Non-U.S. GAAP measure reconciliation for Organic Sales and Segment EBITDA
Net Sales - The net sales for the Electronics segment decreased by $214 million to $179 million for the quarter as compared to 2019. This sales decline was mainly due to the organic sales1 decline in Restraint Control Systems and Active Safety of $105 million and $103 million, respectively, along with the currency translation effects of $6 million.
29


Operating Loss - The operating loss for the Electronics segment of $29 million for the quarter decreased by $72 million as compared to 2019, mainly due to the higher than normal engineering reimbursements and recovery from Nissin Kogyo, which mitigated the negative LVP impact from COVID-19, causing the lower organic sales for the segment.
EBITDA1 - The EBITDA loss for the Electronics segment decreased by $75 million to negative $6 million for the quarter as compared to 2019. This change is mainly due to the operating loss improvement for the segment while depreciation and amortization increased by $3 million.
Associates - Associates in the Electronics segment decreased by 1,058 net to 6,705 as compared to 2019, mainly due to a reduction in engineering of approximately 550 and direct labor of approximately 500. Temporary associates decreased by approximately 450 reflecting the volume decline as compared to 2019.
Deliveries - The deliveries during the quarter were 2.3 million units for Restraint Controls Systems and 0.9 million units for Active Safety.
Brake Systems Segment Three Months Ended June 30 Components of Change vs. Prior Year
(Dollars in millions, except where specified) 2020 2019 US GAAP Reported Change Currency Divestiture
Organic1
$ % $ % $ % $ % $ % $ %
Net Sales   96    (91)   (94)   —    —    (81)   (85)   (10)   (64)  
Operating Loss / Margin (20)   (372.3)   (17)   (18.3)   (3)  
Segment EBITDA1 / Margin
(20)   (365.2)   (7)   (7.4)   (13)  
Associates 350    1,415    (1,065)  
1 Non-U.S. GAAP measure reconciliation for Organic Sales and Segment EBITDA
Net Sales - The net sales for the Brake Systems segment decreased by $91 million to $5 million for the quarter as compared to 2019. The sales decrease was mainly attributable to the VNBS-Asia divestiture of $81 million.
Operating Loss - The operating loss for the Brake Systems segment for the quarter increased $3 million to $20 million as compared to 2019. This change was mainly due to the divestiture of VNBS-Asia where the loss in 2019 was $2 million for the quarter and lower volumes in the remaining legacy Honda business.
EBITDA1 - The EBITDA loss for Brake Systems segment increased by $13 million to negative $20 million for the quarter as compared to 2019. This change was mainly due to the net effect of the VNBS-Asia divestiture and lower amortization of intangibles related to Veoneer Brake Systems (VBS)-US.
Associates - The number of associates in the Brake Systems segment decreased by 1,065 to 350 net as compared to 2019, mainly due to the divestiture impact of 1,080 associates related to VNBS-Asia.
Deliveries - The deliveries during the quarter were 0.012 million units for the Brake Systems segment.
Corporate and Other Three Months Ended June 30
(Dollars in millions, except where specified) 2020 2019 US GAAP Reported Change
$ % $ % $ %
Net Sales $ —    $ —    $ —   
Operating Loss / Margin $ (15)   —  % $ (19)   —  % $  
EBITDA1 / Margin
$ (15)   —  % $ (18)   —  % $  
Associates 40    57 (17)  
1 Non-U.S. GAAP measure reconciliation for EBITDA
Operating Loss and EBITDA1 - The operating loss and EBITDA for Corporate and other for the quarter decreased to $15 million from an operating loss of $19 million and EBITDA of $(18) million in 2019. This decrease was primarily due to lower IT, consultancy and associate related costs.
Associates - The number of associates decreased by 17 to 40 for the quarter as compared to 2019 due to a reduction in temporary associates related to process improvements of being a standalone company.
30


The Veoneer associates and financial figures for the quarter are comparable to 2019 as the second quarter of 2018 was the last quarter of carve-out reporting.
Veoneer Performance
Income Statement Three Months Ended June 30
(Dollars in millions, except per share data) 2020 2019  
$ % $ % Change
Net sales $ 184    $ 489    $ (305)  
Cost of sales (181)   (98.1) % (412)   (84.3) % 231
Gross profit $   1.9  % $ 77    15.7  % $ (74)  
Selling, general & administrative expenses (38)   (20.6) % (50)   (10.3) % 12
Research, development & engineering expenses, net (44)   (24.1) % (159)   (32.4) % 115
Amortization of intangibles (1)   (0.7) % (6)   (1.3) % 5
Other income, net 16 8.7  % 1 0.2  % 15
Operating loss $ (64)   (34.8) % $ (137)   (28.0) % $ 73   
Loss from equity method investments (19)   (10.6) % (18)   (3.6) % (1)  
Interest income   1.4  %   0.9  % (1)  
Interest expense (5)   (2.8) % (2)   (0.4) % (3)  
Other non-operating items, net (3)   (1.4) %   0.2  % (4)  
Loss before income taxes $ (88)   (47.6) % $ (152)   (31.1) % $ 64   
Income tax benefit (expense) (2)   (1.1) % 10 2.0  % (12)  
Net loss1
$ (90)   (48.6) % $ (142)   (29.0) % 52   
Less: Net loss attributable to non-controlling interest —    0.0  % (9)   1.8  % 9
Net loss attributable to controlling interest $ (90)   (48.6) % $ (133)   (27.2) % $ 43   
Net loss per share – basic2
$ (0.80)   $ (1.39)   $ 0.59   
Weighted average number of shares outstanding 2
111.58    96.06    15.52   
1 Including Corporate and other sales. 2 Basic number of shares in millions used to compute net loss per share. Participating share awards without right to receive dividend equivalents are (under the two-class method) excluded from EPS calculation.
Gross Profit - The gross profit for the quarter of $3 million was $74 million lower as compared to 2019, where the negative LVP was the main contributor causing the lower organic sales. Net currency effects and the VNBS-Asia divestiture were $(2) million and $(13) million, respectively.
The RD&E, net of $44 million for the quarter decreased $115 million as compared to 2019, due to lower gross costs and higher engineering reimbursements, where $81 million was related to work previously completed. The VNBS-Asia divestiture benefit was $7 million.
The SG&A expense of $38 million for the quarter decreased $12 million as compared to 2019, due to lower consultancy, IT and associate related costs. The VNBS-Asia divestiture benefit was $4 million.
Other income and amortization of intangibles combined improved $20 million for the quarter as compared to 2019 mainly due to lower amortization of intangibles including $3 million related to the VNBS-Asia divestiture and the $20 million recovery from Nissin Kogyo.
Operating Loss - The operating loss for the quarter of $64 million decreased by $73 million as compared to 2019, despite the decline in organic sales. The VNBS-Asia divestiture benefit was $2 million while net currency effects were $1 million for the quarter.
The interest expense, net for the quarter was $4 million higher as compared to 2019, due to interest expense related to the convertible debt while other operating items, net decreased $4 million due to a $2 million investment loss in 2020 and a $1 million currency gain in 2019.
Income tax expense of $2 million for the quarter was $12 million higher as compared to 2019 mainly due to a discrete tax benefit of $8 million and a $5 million tax benefit from the convertible debt issuance, both in 2019.
31


Net Loss - The net loss for the quarter of $90 million decreased by $52 million as compared to 2019, primarily due to the operating loss improvement. The equity method investment loss increased $1 million as compared to 2019. The non-controlling interest was $9 million higher as compared to 2019 due to the VNBS-Asia divestiture in February 2020.
Loss per Share - The loss per share of $0.80 improved by $0.59 for the quarter as compared to 2019. This decline was mainly due to the operating loss improvement of $0.65 per share while the share count increase from the 2019 capital raise reduced the loss by $0.17.
Six Months Ended June 30, 2020 Compared to Six Months Ended June 30, 2019
The following analysis illustrates Veoneer’s overall and by segment performance for the six months ended June 30, 2020 and 2019 along with components of change compared to the prior year.
Net Sales by Product
The following tables illustrate Veoneer’s consolidated net sales by product for the six months ended June 30, 2020 and 2019 along with components of change compared to the prior year.
Net Sales Six Months Ended June 30 Components of Change vs. Prior Year
(Dollars in millions, except where specified) 2020 2019 US GAAP
Reported Change
Currency Divestiture
Organic1
$ $ $ % $ % $ % $ %
Restraint Control Systems 262    425    (163)   (38)   (9)   (2)   —    —    (154)   (36)  
Active Safety 241    375    (134)   (36)   (7)   (2)   —    —    (127)   (34)  
Brake Systems 43    184    (141)   (77)   —    —    (128)   (70)   (13)   (41)  
Total $ 546    $ 984    $ (438)   (44) % $ (16)   (2) % $ (128)   (13) % $ (294)   (35) %
1 Non-U.S. GAAP measure reconciliation for Organic Sales
Net Sales - Veoneer’s net sales for the first half declined by 44% to $546 million as compared to 2019. The organic sales1 declined by 35%, as compared to the 34% reduction in LVP for the same period. The remainder of the decline was from net currency translation effects of 2% and VNBS-Asia divestiture of 13%.
During the first half, excluding brake systems, the organic sales declined in North America 47%, Europe 27% and Asia 32%, primarily due to the negative impact of COVID-19. These negative effects mostly impacted North America and Europe from mid-March through May and Asia from February through mid-April.
Restraint Control Systems - Net sales for the first half of $262 million decreased by 38% as compared to 2019. The organic sales decline of 36% was primarily due to the LVP decline driving lower volumes in North America and Europe.
Active Safety - Net sales for the first half decreased by 36% to $241 million as compared to 2019. This decline was primarily driven by the organic sales decline of 34%. This performance versus the LVP was driven by our strong product content on premium brands in Europe, where we have a relatively higher CPV than in other markets.
Strong demand for mono, stereo and thermal camera systems and ADAS ECUs on several models drove an increase in organic sales. This growth was more than offset by the volume effect from the product mix shift from our 24Ghz to 77Ghz radar technology and the phase-out of certain mono-vision programs with BMW, and lower underlying LVP mainly driven by the impact of COVID-19.
Brake Systems - Net sales for the first half decreased by 77% to $43 million as compared to 2019. The organic sales decline of 41% was $13 million, however the VNBS-Asia divestiture accounted for a year-over-year decline of $128 million or 70%.
32


Electronics Segment Six Months Ended June 30 Components of Change vs. Prior Year
(Dollars in millions, except where specified) 2020 2019 US GAAP
Reported Change
Currency
Organic1
$ % $ % $ % $ % $ %
Net Sales 503    800    (297)   (37)   (16)   (2)   (281)   (35)  
Operating Loss / Margin (123)   (24.4)   (191)   (23.9)   68   
Segment EBITDA1 / Margin
(78)   (15.5)   (151)   (18.9)   73   
Associates 6,705    7,763    (1,058)  
1 Non-U.S. GAAP measure reconciliation for Organic Sales and Segment EBITDA
Net Sales - The net sales for the Electronics segment decreased by $297 million to $503 million for the first half as compared to 2019. This sales decline was mainly due to the organic sales1 decline in Active Safety and Restraint Control Systems of $127 million and $154 million, respectively, along with the currency translation effects of $16 million.
Operating Loss - The operating loss for the Electronics segment of $123 million for the first half decreased by $68 million as compared to 2019, primarily due to the higher than normal engineering reimbursements, lower RD&E costs and the recovery from Nissin Kogyo, which mitigated the negative LVP impact from COVID-19, and volume and product mix effects causing the lower organic sales for the segment.
EBITDA1 - The EBITDA loss for Electronics segment decreased by $73 million to negative $78 million for the first half as compared to 2019. This change is mainly due to the decrease in operating loss for the segment while depreciation and amortization increased by $5 million.
Associates - Associates in the Electronics segment decreased by 473 net to 6,705 as compared to the previous quarter, mainly due to a reduction in engineering of approximately 180 and direct labor of approximately 200. Temporary associates decreased by approximately 135 reflecting the production volume decline.
Deliveries - The deliveries during the quarter were 6.0 million units for Restraint Controls Systems and 2.7 million units for Active Safety.
Brake Systems Segment Six Months Ended June 30 Components of Change vs. Prior Year
(Dollars in millions, except where specified) 2020 2019 US GAAP Reported Change Currency Divestiture
Organic1
$ % $ % $ % $ % $ % $ %
Net Sales 43    184    (141)   (77)   —    —  % $ (128)   (70)   (13)   (41)  
Operating Loss / Margin (33)   (78.1)   (37)   (20.1)    
Segment EBITDA1 / Margin
(32)   (74.8)   (17)   (9.4)   (15)  
Associates 350    1,415    (1,065)  
1 Non-U.S. GAAP measure reconciliation for Organic Sales and Segment EBITDA
Net Sales - The net sales for the Brake Systems segment decreased by $141 million to $43 million for the first half as compared to 2019. The sales decrease was mainly attributable to the VNBS-Asia divestiture of $128 million.
Operating Loss - The operating loss for the Brake Systems segment for the first half decreased to $33 million from $37 million as compared to 2019. This change was mainly due to the divestiture of VNBS-Asia where the loss in 2019 was $9 million for the first half.
EBITDA1 - The segment EBITDA loss for Brake Systems increased by $15 million to negative $32 million for the first half as compared to 2019. This change was mainly due to the net effect of the VNBS-Asia divestiture.
Associates - The number of associates in the Brake Systems segment of 350 net remained essentially unchanged from the previous quarter.
Deliveries - The deliveries during the first half were 0.2 million units for the Brake Systems.
33


Corporate and Other Six Months Ended June 30
(Dollars in millions, except where specified) 2020 2019 US GAAP Reported Change
$ % $ % $ %
Net Sales $ —    $ —    $ —   
Operating Loss / Margin $ (30)   —  % $ (37)   —  % $  
EBITDA1 / Margin
$ (30)   —  % $ (37)   —  % $  
Associates 40    57    (17)  
1 Non-U.S. GAAP measure reconciliation for EBITDA
Operating Loss and EBITDA1 - The operating loss and EBITDA for Corporate and other for the first half decreased by $7 million from an operating loss of $37 million and EBITDA $(37) million as compared to 2019. This decrease was primarily due to lower IT, consultancy and associate related costs.
Associates - The number of associates decreased by 2 to 40 from the previous quarter due to a reduction in SG&A related to process improvements of being a standalone company.
The Veoneer associates and financial figures for the first half are comparable to 2019 as the second quarter of 2018 was the last quarter of carve-out reporting.
Veoneer Performance
Income Statement Six Months Ended June 30
(Dollars in millions, except per share data) 2020 2019  
$ % $ % Change
Net sales $ 546    $ 984    $ (438)  
Cost of sales (490)   (89.7) % (822)   (83.5) % 332   
Gross profit $ 56    10.3  % $ 162    16.5  % $ (106)  
Selling, general & administrative expenses (82)   (14.9) % (102)   (10.4) % 20   
Research, development & engineering expenses, net (175)   (32.0) % (315)   (32.0) % 140   
Amortization of intangibles (3)   (0.5) % (11)   (1.1) %  
Other income, net 18    3.3  %   0.1  % 17   
Operating loss $ (186)   (34.1) % $ (265)   (27.0) % $ 79   
Loss on divestiture and assets held for sales, net (67)   (12.3) % —    0.0  % (67)  
Loss from equity method investments (38)   (6.9) % (35)   (3.5) % (3)  
Interest income   1.2  %   0.8  % (1)  
Interest expense (10)   (1.8) % (3)   (0.2) % (7)  
Other non-operating items, net (1)   (0.1) %   0.1  % (2)  
Loss before income taxes $ (295)   (54.0) % $ (294)   (29.9) % $ (1)  
Income tax benefit (expense) (26)   (4.7) %   0.5  % (30)  
Net loss1
$ (321)   (58.8) % $ (290)   (29.5) % $ (31)  
Less: Net Income (loss) attributable to non-controlling interest   (0.3) % (20)   2.0  % 21   
Net loss attributable to controlling interest $ (322)   (59.0) % $ (270)   (27.4) % $ (52)  
Net loss per share – basic2
$ (2.89)   $ (2.94)   $ 0.05   
Weighted average number of shares outstanding 2
111.52    91.68    19.84   
1 Including Corporate and other sales. 2 Basic number of shares in millions used to compute net loss per share. Participating share awards without right to receive dividend equivalents are (under the two-class method) excluded from EPS calculation.
Gross Profit - The gross profit for the first half of $56 million was $106 million lower as compared to 2019, where the negative LVP and volume and product mix effects that caused the lower organic sales were the main contributors. Net currency effects and the VNBS-Asia divestiture were $(2) million and $(19) million, respectively.
The RD&E, net of $175 million decreased by $140 million as compared to 2019, due to higher than normal engineering reimbursements and lower gross costs. The VNBS-Asia divestiture benefit was $15 million.
34


The SG&A expense of $82 million for the first half decreased by $20 million as compared to 2019, due to lower consultancy, IT and associate related costs. The VNBS-Asia divestiture benefit was $7 million.
Other income and amortization of intangibles combined were $25 million higher for the first half as compared to 2019 mainly due to lower amortization of intangibles including $7 million related to VNBS-Asia divestiture and $20 million recovery from Nissin Kogyo.
Operating Loss - The operating loss for the first half of $186 million improved by $79 million as compared to 2019, despite the drop in organic sales. The VNBS-Asia divestiture benefit was $10 million while net currency effects were $5 million.
The interest expense, net for the first half was $8 million lower as compared to 2019, due to interest expense related to the convertible debt of $8 million. Other non-operating items, net of $(1) million increased $2 million primarily due to an investment loss in 2020.
Income tax expense of $26 million for the first half was $30 million higher as compared to 2019. This is due to a $4 million discrete tax benefit and $5 million tax benefit from the convertible debt issuance in 2019 and discrete tax expense of $22 million on the VNBS sale in 2020. The non-controlling interest expense was $21 million unfavorable as compared to 2019. This is due to the exclusion of VBS-US from non-controlling interest and the divestiture of VNBS-Asia.
Net Loss - The net loss for the first half of $321 million increased by $31 million as compared to 2019, primarily due to the combined $67 million net loss, from the divestiture gain on VNBS-Asia of $77 million and the impairment of VBS-US assets held for sale of $(144) million, while the equity method investment loss increased by $3 million.
Loss per Share - The loss per share of $2.89 for the first half decreased by $0.05 as compared to 2019. The lower operating loss more than off-setting the combined net loss from the VNBS-Asia divestiture gain, and VBS-US impairment. The share count increase from the equity raise in 2019 reduced the loss by $0.70 per share.
Non-U.S. GAAP Financial Measures
Non-U.S. GAAP financial measures are reconciled throughout this report.
In this report we refer to organic sales or changes in organic sales growth, a non-U.S. GAAP financial measure that we, investors and analysts use to analyze the Company's sales trends and performance. We believe that this measure assists investors and management in analyzing trends in the Company's business because the Company generates approximately 68% of its sales in currencies other than in U.S. dollars (its reporting currency) and currency rates have been and can be rather volatile. Organic sales and organic sales growth represent the increase or decrease in the overall U.S. dollar net sales and percentage change on a comparable basis thereby excluding any structural impacts. This facilitates separate discussions of the impact of acquisitions and divestitures and exchange rates on the Company’s performance. The tables in this report present the reconciliation of the changes in the total U.S. GAAP net sales to changes in organic sales growth.
The Company uses in this report EBITDA, a non-U.S. GAAP financial measure, which represents the Company’s net income excluding interest expense, income taxes, depreciation and amortization and loss from equity method investment. The Company also uses Segment EBITDA, a non-U.S. GAAP financial measure, which represents the Company’s EBITDA which has been further adjusted on a segment basis to exclude certain corporate and other items. We believe that EBITDA and Segment EBITDA are useful measures for management, analysts and investors to evaluate operating performance on a consolidated and reportable segment basis, because it assists in comparing our performance on a consistent basis. The tables below provide reconciliations of net income (loss) to EBITDA and Segment EBITDA.
The Company uses in this report net working capital, a non-U.S. GAAP financial measure, which is defined as current assets (excluding cash and cash equivalents) minus current liabilities excluding short-term debt and net assets and liabilities held for sale. The Company also uses in this report cash flow before financing activities, a non-U.S. GAAP financial measure, which is defined as net cash used in operating activities plus net cash used in investing activities. Management uses these measures to improve its ability to assess operating performance at a point in time as well as the trends over time. The tables below provide a reconciliation of current assets and liabilities to net working capital and cash flow before financing activities.
Investors should not consider these non-U.S. GAAP measures as substitutes, but rather as additions, to financial reporting measures prepared in accordance with U.S. GAAP. These measures, as defined, may not be comparable to similarly titled measures used by other companies.
Forward-looking non-U.S. GAAP financial measures used in this report are provided on a non-U.S. GAAP basis. Veoneer has not provided a U.S. GAAP reconciliation of these measures because items that impact these measures, such as foreign currency
35


exchange rates and future investing activities, cannot be reasonably predicted or determined. As a result, such reconciliations are not available without unreasonable efforts and Veoneer is unable to determine the probable significance of the unavailable information.
Reconciliations of U.S. GAAP to Non-U.S. GAAP Financial Measures
Net Loss to EBITDA Three Months Ended June 30 Six Months Ended June 30 Last 12
Months
Full Year
2019
Dollars in millions 2020 2019 2020 2019
Net Loss $ (90)   $ (142)   $ (321)   $ (290)   $ (552)   $ (522)  
Net loss on divestiture and assets held for sale —    —    67      67    —   
Depreciation and amortization 23    31    46    60    101    115   
Loss from equity method investment 19    18    38    35    73    70   
Interest and other non-operating items, net   (3)     (6)     (9)  
Income tax expense (benefit)   (10)   26    (4)   30     
EBITDA $ (41)   $ (106)   $ (140)   $ (205)   $ (279)   $ (345)  

Segment EBITDA to EBITDA Three Months Ended June 30 Six Months Ended June 30 Last 12
Months
Full Year
2019
Dollars in millions 2020 2019 2020 2019
Electronics $ (6)   $ (81)   $ (78)   $ (151)   $ (169)   $ (242)  
Brake Systems (20)   (7)   (32)   (17)   (46)   (32)  
Segment EBITDA $ (26)   $ (88)   $ (110)   $ (168)   $ (215)   $ (274)  
Corporate and other (15)   (18)   (30)   (37)   (64)   (71)  
EBITDA $ (41)   $ (106)   $ (140)   $ (205)   $ (279)   $ (345)  

Working Capital to Net Working Capital June 30, 2020 June 30, 2019 March 31, 2020 March 31, 2019 December 31, 2019 December 31, 2018
Dollars in millions
Total current assets $ 1,260    $ 1,758    $ 1,407    $ 1,352    $ 1,649    $ 1,543   
less Total current liabilities 429    572    507    593    591    636   
Working Capital $ 831    $ 1,185    $ 900    $ 759    $ 1,058    $ 907   
less Cash and cash equivalents (851)   (1,204)   (970)   (715)   (859)   (864)  
less Short-term debt 20    20      —      —   
less Net of Assets and Liabilities held for sale (11)   —    (19)   —    (199)   —   
Net Working Capital $ (11)   $   $ (86)   $ 44    $   $ 42   

Cash Flow before Financing Activities Three Months Ended June 30 Six Months Ended June 30 Last 12
Months
Full Year
2019
Dollars in millions 2020 2019 2020 2019
Net cash used in Operating Activities $ (107)   $ (70)   $ (116)   $ (160)   $ (281)   $ (325)  
Plus Net cash provided by (used in) Investing Activities (34)   (65)   99    (119)   (47)   (265)  
Cash flow before Financing Activities $ (141)   $ (135)   $ (17)   $ (279)   $ (328)   $ (590)  

Liquidity and Capital Resources
Liquidity
As of June 30, 2020, the Company had cash and cash equivalents of $851 million.
The Company's primary source of liquidity is its existing cash balance of $851 million, which will primarily be used for ongoing working capital requirements and capital expenditures. The Company believes that its existing cash resources will be sufficient to support its current operations for at least the next twelve months.
36


The Company has no material obligations other than short-term obligations related to operations, inventory, services, tooling, and property, plant and equipment purchased in the ordinary course of business.
Autotech - On June 30, 2017, Veoneer committed to make a $15 million investment in Autotech Fund I, L.P. pursuant to a limited partnership agreement, and, as a limited partner, will periodically make capital contributions toward this total commitment amount. As of June 30, 2020, Veoneer contributed a total of $12 million to the fund. The initial term of the fund is set to expire on December 31, 2025. This fund focuses broadly on the automotive industry and complements the Company’s innovation strategy, particularly in the areas of active safety and autonomous driving. Under the limited partnership agreement, the general partner has the sole and exclusive right to manage, control, and conduct the affairs of the partnership.
Zenuity - On April 2, 2020 Veoneer and Volvo Cars announced a preliminary agreement to separate the Zenuity JV, allowing each company to focus on their strategic priorities. The parties entered into definitive agreements and effected the separation on July 1, 2020. Prior to the separation and during the second quarter the Company made a funding contribution to the joint venture of $9 million.
Capital Raise - On May 28, 2019, Veoneer closed its concurrent registered public offerings of common stock and convertible senior notes. The offerings, which were oversubscribed by approximately three times, resulted in gross proceeds of $627 million, consisting of $420 million from the common stock offering and $207 million from the convertible notes offering. 24 million shares of common stock were issued in the common stock offering.
VNBS - On October 30, 2019, Veoneer signed definitive agreements to sell its 51% ownership in Veoneer Nissin Brake Japan ("VNBJ") and Veoneer Nissin Brake China ("VNBZ"), the entities that comprised VNBS at the time of such agreements, referred to herein as “VNBS-Asia”, to its joint venture partner Nissin-Kogyo Co., Ltd., and Honda Motor Co., Ltd. The aggregate purchase price was $176 million. The divestiture was completed on February 3, 2020 under the definitive agreements, and the VNBS joint venture was terminated.
Cash Flows
Selected Cash flow items Six Months Ended June 30
(Dollars in millions, except where specified) 2020 2019
Net working capital 1
$ (11)   $  
Net cash used in operating activities $ (116)   $ (160)  
Capital expenditures $ (51)   $ (109)  
Equity method investments $ (25)   $ (11)  
Net cash provided by (used in) investing activities $ 99    $ (119)  
Cash flow before financing activities 1
$ (17)   $ (279)  
Net cash provided by (used in) financing activities $   $ 629   
1 Non-U.S. GAAP measure, see reconciliation above
Net Working Capital1 - The positive change in net working capital of $14 million for the first half was due to the $30 million reversal of timing effects at year-end and further improvements in receivables partially offset by the negative COVID-19 timing effects in the second quarter.
Days receivables outstanding, outstanding receivables relative to average daily sales was 90 days for June 30, 2020, as compared to 54 days at June 30, 2019. This increase is mainly due to the majority of the sales for the second quarter this year occurred during the second half of the quarter and remain uncollected at the end of the quarter. Days inventory outstanding, outstanding inventory relative to average daily sales, increased to 66 days as of June 30, 2020, as compared to 29 days at June 30, 2019. This ratio increased year-over-year due the sharp ramp-up of production during the second half of the quarter and the need to maintain minimum inventory stock to avoid customer shutdowns. Both of these ratio deteriorated during the quarter due to the COVID-19 pandemic.
Net cash used in operating activities - Net cash used in operating activities of $116 million during the first half was $44 million favorable as compared to 2019. The improvement was primarily driven by the net working capital improvement and the lower operating loss.
37


Capital Expenditures - Capital expenditures of $51 million for the first half decreased by $58 million as compared to 2019 mainly due to lower investments in VBS-US, facility expansions, and engineering related IT. The benefit of the VNBS-Asia divestiture was $16 million.
Net cash proceeds from investing activities - Net cash proceeds from investing activities of $99 million during the first half was $218 million higher as compared to 2019. This was due to lower capital expenditures of $58 million and the VNBS-Asia divestiture of $176 million.
Cash flow before financing activities1 - The cash flow before financing activities of $(17) million for the first half was $262 million better as compared to 2019 mainly due to improved net working capital, lower capital expenditures and the VNBS-Asia divestiture.
Number of Associates
June 30,
2020
March 31,
2020
December 31,
2019
September 30,
2019
June 30,
2019
TOTAL 7,095 7,571 8,874 9,127 9,235
Whereof: Direct Manufacturing 1,130 1,326 2,002 2,116 2,153
RD&E 4,404 4,590 4,907 5,086 5,154
Temporary 1,031 1,166 1,396 1,630 1,659
The net number of associates decreased by 476 to 7,095 during the quarter as compared to 7,571 in the previous quarter. The Company had close to 15% of its full-time equivalent workforce on furlough, layoff or short work weeks during the quarter while close to 4,500 associates have been working remotely since mid-March.
The decrease of 476 associates was mainly due to reductions in direct manufacturing and RD&E of 196 and 186, respectively. Temporary associates declined by 135 during the quarter. Overall, these reductions are primarily a result of our MAIs to mitigate the negative impact of COVID-19 on our business and engineering efficiency improvements.
The net number of associates decreased by 2,140 to 7,095 during the quarter from 9,235 as compared to the second quarter in 2019. The VNBS-Asia divestiture effect on the decline was 1,080 associates.
The underlying Veoneer decrease of 1,060 associates, as compared to the second quarter in 2019, was mainly due to reductions in direct manufacturing and RD&E of 504 and 534, respectively, while temporary associates declined by 628 as compared to the second quarter in 2019. These reductions are primarily a result of our MAIs to mitigate the impact of the negative impact of COVID-19 on our business and engineering efficiency improvements.
Significant Legal Matters
For discussion of legal matters we are involved in, see Note 13 "Contingent Liabilities", to the condensed consolidated financial statements included herein.
Off-Balance Sheet Arrangements and Other Matters
The Company does not have any off-balance sheet arrangements that have, or are reasonably likely to have, a material current or future effect on its financial position, results of operations or cash flows.
Contractual Obligations and Commitments
Except as set forth below, there have been no significant changes to the contractual obligations and commitments disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 21, 2020.
On May 28, 2019, the Company issued, in a registered public offering in the U.S., the Notes with an aggregate principal amount of $207 million. The Notes bear interest at a rate of 4.00% per year payable semi-annually in arrears on June 1 and December 1 of each year. The Notes will mature on June 1, 2024, unless repurchased, redeemed or converted in accordance with their terms prior to such date.
Significant Accounting Policies and Critical Accounting Estimates
See Note 2 “Summary of Significant Accounting Policies” to the accompanying condensed consolidated financial statements included herein.
38


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As of June 30, 2020, there have been no material changes to the information related to quantitative and qualitative disclosures about market risk that was provided in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 21, 2020.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of June 30, 2020, our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed by us in this Quarterly Report on Form 10-Q was (a) reported within the time periods specified by SEC rules and regulations, and (b) communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding any required disclosure.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

39


PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Various claims, litigation and proceedings are pending or threatened against the Company or its subsidiaries, covering a range of matters that arise in the ordinary course of its business activities with respect to commercial, product liability and other matters.
For a description of our material legal proceedings, see Note 13 Contingent Liabilities – Legal Proceedings to our unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q, which is incorporated herein by reference.
ITEM 1A. RISK FACTORS
Other than as set forth below, there have been no material changes in the risk factors described in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors below and also those discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, which could materially affect our business, financial condition or future results. The risks described below and in our Annual Report on Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results.
Our business and financial condition may be materially and adversely affected by the ongoing novel coronavirus (COVID-19) pandemic.
The impact of the COVID-19 pandemic, including widespread illness, market downturns, restrictions on business and individual activities, changes in consumer behavior, and uncertainty regarding the future course of the pandemic, has created significant volatility in the global economy and led to a steep drop in economic activity. While we have taken numerous steps to mitigate the impact of the pandemic on our results of operations, there can be no assurance that these efforts will be successful, This COVID-19 pandemic has significantly disrupted, and may continue to disrupt, the automotive industry, light vehicle production (“LVP”) and automotive sales in markets around the world. Such disruptions include the manufacturing, delivery and overall supply chain of automobile manufacturers and suppliers. Global LVP has decreased significantly since early 2020 and during the second quarter some vehicle manufacturers temporarily ceased manufacturing operations in some countries and regions, including the United States and Europe As a result, we have experienced, and may continue to experience, declines in the production and distribution of our products and the loss of sales to our customers. As production resumes, production volumes have been and may continue to be volatile.
If the global economic effects caused by the pandemic continue or increase, overall customer demand may continue to decline which would have a material and adverse effect on our business, results of operations and financial condition.
Given the high level of research and development ("R&D") spend that is required to develop and launch our products, a sustained decline in LVP or vehicle sales may delay the return on our investment in R&D and a return on the resources expended to ensure timely and quality launches, which could have a material adverse effect on our financial condition and results of operations. A prolonged downturn in regional and global economic conditions or LVP would likely result in us experiencing a significantly negative cash flow.
In addition, if the COVID-19 pandemic continues or worsens and a significant portion of our workforce, our suppliers’ workforce, or our customers’ workforce are affected, either directly or due to new or extended government closures or otherwise, associated work stoppages or facility closures would halt or further delay production.
The full impact of the COVID-19 pandemic on our financial condition and results of operations will depend on future developments, such as the ultimate duration and scope of the outbreak, its impact on our customers and suppliers, how quickly, and to what extent normal economic and operating conditions, and the demand for our products can resume and whether the pandemic leads to recessionary conditions in any of our key markets that may continue to impact customer demand and the financial instability or operating viability of our suppliers and customers. Accordingly, the ultimate impact of the COVID-19 pandemic on our financial condition and results of operations cannot be determined at this time. Despite the uncertainty of the COVID-19 situation, we expect our full year 2020 results of operations to be adversely affected.
In addition to the risks specifically described above, the impact of COVID-19 is likely to implicate and exacerbate other risks disclosed in Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2019, including, but not limited to, our program launches, demand or market acceptance for our products, disruptions in our supply or delivery chain, shifting customer preferences, our employees and cyber-security threats.
40


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Not applicable.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
Not applicable.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
Not applicable.

41


ITEM 6. EXHIBITS
Exhibit No.   Description
3.1
3.2
4.1
4.2
4.3
10.1*+
31.1*
 
     
31.2*
 
     
32.1*
 
     
 
     
101*   The following financial information from the Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2020, formatted Inline XBRL (Extensible Business Reporting Language) and filed electronically herewith: (i) the Condensed Consolidated Statements of Operations (Unaudited); (ii) the Condensed Consolidated Statements of Comprehensive Loss (Unaudited); (iii) the Condensed Consolidated Balance Sheets; (iv) Condensed Consolidated Statements of Changes in Equity (Unaudited); (v) the Condensed Consolidated Statements of Cash Flows; and (vi) Notes to unaudited condensed consolidated financial statements.
104*   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

* Filed herewith.
+ Management contract or compensatory plan.

42


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: July 24, 2020
VEONEER, INC.
(Registrant)
 
By: /s/ Mats Backman
  Mats Backman
  Chief Financial Officer
  (Duly Authorized Officer and Principal Financial Officer)

43

Exhibit 10.1

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into on May 6, 2020 by and between Veoneer Inc., a Delaware corporation (the “Company”), and Christer Lundström (the “Executive”), to be effective as of the Effective Date, as defined in Section 1. References herein to the “Company” shall, as applicable, be deemed to include the Company’s affiliates.
BACKGROUND
The Company desires to engage the Executive as the Executive Vice President, Quality of the Company from and after the Effective Date, in accordance with the terms of this Agreement. The Executive is willing to serve as such in accordance with the terms and conditions of this Agreement.
NOW THEREFORE, in consideration of the foregoing and of the mutual covenants and agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
1.Effective Date The effective date of this Agreement (the “Effective Date”) shall be May 6, 2020, or such other date to which the parties agree.
2.Employment. The Executive is hereby employed on the Effective Date as the Executive Vice President, Quality of the Company. In this capacity, the Executive shall have the duties, responsibilities and authority commensurate with such position as shall be assigned to him by the Chief Executive Officer of the Company (the “Chief Executive Officer”). The principal workplace for the Executive shall be Vårgårda, Sweden.
3.Employment Period. The Company hereby agrees to employ the Executive and the Executive hereby agrees to serve the Company from the Effective Date and thereafter unless and until terminated by the Company or the Executive (the “Employment Period”); provided, however, that (i) the Company must give the Executive written notice of termination of the Executive’s employment not less than six (6) calendar months prior to such date of termination, and (ii) the Executive must give the Company written notice of termination of his employment not less than six (6) calendar months prior to such date of termination; provided, further, however, that in the event of a termination by the Company for Cause pursuant to Section 10(b) hereof, the 6-month notice requirement provided in clause (i) of the foregoing provision shall not apply and the Executive’s termination of employment shall be effective immediately. Notwithstanding the foregoing, the Executive’s employment shall automatically terminate on the earlier occurrence of the end of notice period or the last day of the month preceding the Executive’s 65th birthday (“Retirement”).
4.Extent of Service. During the Employment Period, the Executive shall use his best efforts to promote the interests of the Company and those of any parent, subsidiary and associated company of the Company, and shall devote his full time and attention during normal business hours to the business and affairs of the Company and any parent, subsidiary and associated company. In addition, the Executive shall devote as much time outside normal business hours to the performance of his duties as may in the interests of the Company be reasonably necessary; provided, however, that the Executive shall not receive any remuneration in addition to that set out in Section 5 hereof in respect of his work during such time. During the Employment Period, the Executive shall not, without the consent of the Chief Executive Officer, directly or indirectly, either alone or jointly with or as a director, manager, agent or servant of any other person, firm or company, be engaged, concerned or interested in any business in a manner that would conflict with the Executive’s duties under this Section 4 (including holding any shares, loan, stock or any other ownership interest in any competitor of the Company), provided that nothing in this Section 4 shall preclude the Executive from holding shares, loan, stock or any other ownership interest in an entity other than a competitor of the Company as an investment.




5.Compensation and Benefits.
(a)Base Salary. During the Employment Period, the Executive shall receive a gross salary at the rate of SEK 1,900,000 per year (“Base Salary”), less normal withholdings, payable in equal bi-weekly or other installments as are or become customary under the Company’s payroll practices for its employees from time to time. The Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”) shall review the Executive’s Base Salary annually during the Employment Period. Any adjustments to the Executive’s annual base salary shall become the Executive’s Base Salary for purposes of this Agreement.
(b)Bonus. During the Employment Period, the Executive shall be eligible to participate in the Company’s bonus plan for executive officers, if any, pursuant to which he will have an opportunity to receive an annual bonus based upon the achievement of performance goals established from year to year by the Compensation Committee (such bonus earned at the stated “target” level of achievement being referred to herein as the “Target Bonus”). Until otherwise changed by the Compensation Committee, the Executive’s Target Bonus shall be twenty-five percent (25%) of his Base Salary.
(c)Equity Incentive Compensation. During the Employment Period, the Executive shall be eligible for equity grants under the Veoneer, Inc. 2018 Stock Incentive Plan (the “Veoneer Plan”), or any successor plan or plans, having such terms and conditions as awards to other peer executives of the Company, as determined by the Compensation Committee in its sole discretion, unless the Executive consents to a different type of award or different terms of such award than are applicable to other peer executives of the Company. Nothing herein requires the Compensation Committee to grant the Executive equity awards or other long-term incentive awards in any year.
(d)Sign-on/Retention Bonus.  The Executive shall be entitled to a payment of SEK 1,000,000 to be paid on December 2020 payroll provided that the Executive remains employed by the Company on December 15, 2020 and has not given notice of termination of the employment and has been continuously employed by the Company as of the effective date.
(e)Automobile. The Company shall provide the Executive with a company car or, if consistent with local policies where the Executive is based, a car allowance. If a company car is provided, the Executive and his immediate family may also use the company car for personal purposes and the Company shall bear all petrol, maintenance and repair costs, as well as insurance costs and vehicle tax related to the Company car. If a car allowance is provided, the Company shall also bear all petrol, maintenance and repair cost. but no other costs for the automobile in addition to the allowance. Whether a company car or a car allowance is provided, the Executive shall be liable for the payment of tax on the car allowance or on the taxable benefit resulting from the right to use the company car for personal purposes.
(f)Medical Benefits. During the Employment Period, the Employee and his spouse or significant other is entitled to the Skandia Medical Care Insurance, or any successor arrangement or plan having similar terms and conditions.
(g)Expenses. The Executive shall be entitled to receive payment or reimbursement for all reasonable traveling, hotel and other expenses incurred by him in the performance of his duties under this Agreement, in accordance with the policies, practices and procedures of the Company as in effect from time to time. The Executive shall provide the Company with receipts, vouchers or other evidence of actual payment of the expenses to be reimbursed, as requested by the Company.
(h)Conditions of Employment. Normal conditions of employment as issued by the Company apply to the receipt of benefits under this Section 5.
6.Vacation. The Executive shall be entitled to yearly vacation amounting to 30 days.
7.Pension and benefits. During the Employment Period the Company shall pay pension premiums for pension insurance ITP2, or if higher, with an amount equal to thirty-five percent (35%) of the Employee’s Base
- 2 -


Salary. The pension premiums shall include premiums under the ITP plan, giving the Employee certain benefits in the event of his temporary or permanent illness. The insurance shall be taken out at a reputable insurance company, to be approved of in advance by the Company.
8.Business or Trade Information. The Executive shall not during or after the termination of his employment hereunder disclose to any person, firm of company whatsoever or use for his own purpose or for any purposes other than those of the Company any information relating to the Company (including any parent, subsidiary or associated company of the Company) or its business or trade secrets of which he has or shall hereafter become possessed. These restrictions shall cease to apply to any information which may come into the public domain (other than by breach of the provisions hereof). In the event that the Executive does not comply with this Section 8, the Company shall be entitled to damages equal to six (6) times the average monthly Base Salary that the Executive received during the preceding twelve (12) months, if the Executive continues to be employed, or during the last twelve (12) months prior to his Date of Termination, if the Executive’s employment has terminated; provided, however, that nothing in this Section 8 shall preclude the Company from pursuing arbitration in accordance with Section 16 herein and seeking additional damages from the Executive in the event that the Company is able to demonstrate to the arbitrators that the value of the damages incurred by the Company due to the Executive’s violation of this Section 8 exceed the aggregate value of the damages paid by the Executive to the Company pursuant to the foregoing provision.
9.Company Property. The Executive shall upon the termination of his employment hereunder for whatever reason immediately deliver to the Company all designs, specifications, correspondence and other documents, papers, the car provided hereunder and all other property belonging to the Company or any of its affiliated companies or which may have been prepared by him or have come into his possession in the course of his employment.
10.Termination of Employment.
(a)Death; Retirement. The Executive’s employment shall terminate automatically upon his death or Retirement.
(b)Termination by the Company. The Company may terminate the Executive’s employment during the Employment Period with or without Cause. “Cause” for termination by the Company of the Executive’s employment shall mean (i) willful and continued failure by the Executive to substantially perform the Executive’s duties with the Company (other than any such failure resulting from the Executive’s incapacity due to physical or mental illness) after a written demand for substantial performance is delivered to the Executive by the Board of Directors of the Company (the “Board”), which demand specifically identifies the manner in which the Board believes that the Executive has not substantially performed the Executive’s duties, or (ii) the willful engaging by the Executive in conduct which is demonstrably and materially injurious to the Company, monetarily or otherwise. For purposes of clauses (i) and (ii) of this definition, (x) no act, or failure to act, on the Executive’s part shall be deemed “willful” unless done, or omitted to be done, by the Executive not in good faith and without reasonable belief that the Executive’s act, or failure to act, was in the best interest of the Company and (y) in the event of a dispute concerning the application of this provision, no claim by the Company that Cause exists shall be given effect unless the Chief Executive Officer and the Executive Vice President of Human Resources of the Company establish to the Board by clear and convincing evidence that Cause exists, subject to Section 10(f) hereof.
(c)Termination by the Executive. The Executive may terminate his employment during the Employment Period with Good Reason or without Good Reason. “Good Reason” shall mean the occurrence, without the Executive’s express written consent, of any of the following “Good Reason Events”:
(i)the assignment to the Executive of any duties inconsistent with the Executive’s status as an executive officer of the Company or a substantial adverse alteration in the nature or status of the Executive’s responsibilities from those in effect on the Effective Date other than any such alteration primarily attributable to the fact that the Company may no longer be a public company;
- 3 -


(ii)a reduction by the Company in the Executive’s annual base salary as in effect on the Effective Date or as the same may be increased from time to time;
(iii)the relocation of the Executive’s principal place of employment to location more than 45 kilometers from the Executive’s principal place of employment on the Effective Date or the Company’s requiring the Executive to be based anywhere other than such principal place of employment (or permitted relocation thereof) except for required travel on the Company’s business to an extent substantially consistent with the Executive’s present business travel obligations;
(iv)the failure by the Company to pay to the Executive any portion of the Executive’s current compensation within seven (7) days of the date such compensation is due;
(v)the failure by the Company to continue in effect any compensation plan in which the Executive participates on the Effective Date which is material to the Executive’s total compensation, unless an equitable arrangement (embodied in an ongoing substitute or alternative plan) has been made with respect to such plan, or the failure by the Company to continue the Executive’s participation therein (or in such substitute or alternative plan) on a basis not materially less favorable, both in terms of the amount or timing of payment of benefits provided and the level of the Executive’s participation relative to other participants, as existed on the Effective Date; or
(vi)the failure by any successor to the business of the Company (whether direct or indirect, by purchase, merger, consolidation or otherwise) to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.
A termination by the Executive shall not constitute termination for Good Reason unless the Executive shall first have delivered to the Company written notice setting forth with specificity the occurrence deemed to give rise to a right to terminate for Good Reason (which notice must be given no later than 90 days after the initial occurrence of such event), and there shall have passed a reasonable time (not less than 30 days) within which the Company may take action to correct, rescind or otherwise substantially reverse the occurrence supporting termination for Good Reason as identified by the Executive. The Executive’s termination for Good Reason must occur within a period of 160 days after the occurrence of an event of Good Reason. The Executive’s right to terminate employment for Good Reason shall not be affected by the Executive’s incapacity due to physical or mental illness. The Executive’s continued employment shall not constitute consent to, or a waiver of rights with respect to, any act or failure to act constituting Good Reason hereunder. Good Reason shall not include the Executive’s death.
(d)Notice of Termination. Any termination by the Company or the Executive of the Executive’s employment (other than by reason of death) shall be communicated by written Notice of Termination from one party hereto to the other party hereto. For purposes of this Agreement, a “Notice of Termination” shall mean a written notice which shall (i) indicate the specific termination provision in this Agreement relied upon, (ii) set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the provision so indicated, and (iii) specifies the termination date. Further, a Notice of Termination for Cause is required to include a copy of a resolution duly adopted by the affirmative vote of not less than three-quarters (3/4) of the entire membership of the Board at a meeting of the Board which was called and held for the purpose of considering such termination (after reasonable notice to the Executive and an opportunity for the Executive, together with the Executive’s counsel, to be heard before the Board) finding that, in the good faith opinion of the Board, the Executive was guilty of conduct set forth in clause (i) or (ii) of the definition of Cause herein, and specifying the particulars thereof in detail. The failure by the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Cause shall not waive any right of the Company hereunder or preclude the Company from asserting such fact or circumstance in enforcing the Company’s rights hereunder.
- 4 -


(e) Date of Termination. “Date of Termination” means (i) if the Executive’s employment is terminated other than by reason of death or Retirement, the end of the notice period specified in Section 3 hereof (if applicable), or (ii) if the Executive’s employment is terminated by reason of death, the Date of Termination shall be the date of death of the Executive, or (iii) if the Executive’s employment is terminated by reason of Retirement, the Date of Termination shall be the date of Retirement.
(f)  Dispute Concerning Termination. Any disputes regarding the termination of the Executive’s employment shall be settled in accordance with Section 16 hereof (including, without limitation, the provisions regarding costs and expenses related to arbitration). If within fifteen (15) days after any Notice of Termination is given, or, if later, prior to the Date of Termination (as determined without regard to this Section 10(f)), the party receiving such Notice of Termination notifies the other party that a dispute exists concerning the termination, the Date of Termination shall be extended until the date on which the dispute is finally resolved, either by mutual written agreement of the parties or by a final judgment, order or decree of the arbitrators (which is not appealable or with respect to which the time for appeal there from has expired and no appeal has been perfected); provided, however, that the Date of Termination shall be extended by a notice of dispute given by the Executive only if such notice is given in good faith and the Executive pursues the resolution of such dispute with reasonable diligence.
(g)  Compensation During Dispute. If the Date of Termination is extended in accordance with Section 10(f) hereof, the Company shall continue to provide the Executive with the compensation and benefits specified in Section 5 hereof until the Date of Termination, as determined in accordance with Section 10(f) hereof. Amounts paid under this Section 10(g) are in addition to all other amounts due under this Agreement and shall not be offset against or reduce any other amounts due under this Agreement; provided, however, that in the event that the arbitration results in a determination that the Executive is not entitled to the severance payments set forth in Section 11(a) hereof, then the Executive shall be obligated to promptly repay to the Company the compensation received by the Executive during the extended period pursuant to this Section 10(g).
11.Obligations of the Company Upon Termination of Employment.
(a)Termination by the Company Other Than for Cause; Termination by the Executive for Good Reason. If, during the Employment Period, the Company shall terminate the Executive’s employment other than for Cause, or the Executive shall terminate employment for Good Reason, then the Executive shall be subject to the covenants set forth in Section 13 herein, and only if within forty-five (45) days after the Date of Termination the Executive shall have executed a separation agreement containing a full general release of claims and covenant not to sue, in the form provided by the Company, and such separation agreement shall not have been revoked within such time period, within sixty (60) days after the Date of Termination (or such later date as may be required pursuant to Section 20(c) herein), the Company shall pay to the Executive a lump sum severance payment, in cash, equal to one and a half times (1.5x) the Executive’s Base Salary as in effect immediately prior to the Date of Termination.
(b)Death. If the Executive’s employment is terminated by reason of the Executive’s death during the Employment Period, this Agreement shall terminate without further obligations to the Executive or the Executive’s legal representatives under this Agreement, other than such death benefits he or they would otherwise be entitled to receive under any plan, program, policy or practice or contract or agreement of the Company or its affiliated companies.
(c)Retirement. If the Executive’s employment is terminated in connection with his Retirement during the Employment Period, this Agreement shall terminate without further obligations to the Executive; provided, however, that the Executive shall nonetheless be subject to the covenants set forth in Section 13 herein.
(d)Cause; Voluntary Resignation. If the Executive’s employment is terminated by the Company for Cause during the Employment Period, or the Executive voluntarily resigns his employment without Good Reason, this Agreement shall terminate without further obligations to the Executive; provided, however, that the Executive shall nonetheless be subject to the covenants set forth in Section 13 herein.
- 5 -


12.Non-Duplication of Benefits. Notwithstanding anything to contrary in this Agreement, the aggregate of any amounts payable to the Executive by the Company pursuant to Section 5 (including any compensation and benefits paid pursuant to such section during any applicable termination notice period pursuant to Section 3), Section 10(g) or Section 11 herein shall be offset and reduced to the extent necessary by any other compensation or benefits of the same or similar type, including those payable under local laws of any relevant jurisdiction, so that such other compensation or benefits, if any, do not augment the aggregate of any amounts payable to the Executive by the Company pursuant to Section 5 (including any compensation and benefits paid pursuant to such section during any applicable termination notice period pursuant to Section 3), Section 10(g) or Section 11 herein. It is intended that this Agreement not duplicate compensation or benefits the Executive is entitled to under country “redundancy” laws, the Company’s severance policy, if any, any related or similar policies, or any other contracts, agreements or arrangements between the Executive and the Company.
13.Non-Competition Covenant; Payment for Non-Competition Covenant.
(a)During the twelve (12) months immediately following the termination of his employment with the Company for any reason, the Executive shall not (i) accept employment with a competitor of the Company in a capacity in which such competitor can make use of the confidential information relating to the Company that the Executive has obtained in his employment with the Company, (ii) engage as a partner or owner in such competitor of the Company, nor (iii) act as an advisor to such competitor (the “Non-Competition Covenant”).
(b)If the Executive does not comply with the Non-Competition Covenant when applicable, then (i) the Executive shall not be entitled to any benefits pursuant to Section 13(c) below during the period in which the Executive is not in compliance with such Non-Competition Covenant, and (ii) the Company shall be entitled to damages equal to six (6) times the average monthly Base Salary that the Executive received during the last twelve (12) months prior to the Date of Termination.
(c)The Company may unilaterally waive the Non-Competition Covenant in its sole discretion. If the Company waives the Non-Competition Covenant, then the Executive shall not be entitled to any payments pursuant to Section 13(d).
(d)If the Non-Competition Covenant becomes operative, then the Company shall pay to the Executive, as compensation for the inconvenience of such Non-Competition Covenant, up to twelve (12) monthly payments equal to the Executive’s monthly Base Salary as in effect on the Date of Termination, less the monthly salary earned during such month by the Executive in a subsequent employment, if any; provided, however, that the aggregate monthly payments from the Company pursuant to this Section 13(d) shall not exceed sixty percent (60%) of the Executive’s annual Base Salary as in effect on the Date of Termination, and once the 60% aggregate amount has been paid, no further payments will be made under this Section 13(d). As a condition to the receipt of such payments, the Executive must inform the Company of his base salary in his new employment on a monthly basis. No payments shall be made under this Section 13 if the Executive’s employment is terminated in connection with his Retirement.
14.Inventions.
(a)The general nature of any discovery, invention, secret process or improvement made or discovered by the Executive during the period of the Executive’s employment by the Company (hereinafter called “the Executive’s Inventions”) shall be notified by the Executive to the Company forthwith upon it being made or discovered.
(b)The entitlement as between the Company and the Executive to the Executive’s Inventions shall be determined in accordance with the current Act (1949:345) on the Right to Inventions made by Employees and the Executive acknowledges that because of the nature of his duties and the particular responsibilities arising therefrom he has a special obligation to further the interests of the Company’s undertaking.
- 6 -


(c)Where the Executive’s Inventions are to be assigned to the Company, the Executive shall make a full disclosure of the same to the Company and if and whenever required to do so shall at the expense of the Company apply, singly or jointly with the Company or other persons as required by the Company, for letters patent or other equivalent protection in Sweden and in any other part of the world of the Executive’s Inventions.
15.Entire Agreement. This Agreement supersedes any other previous agreements and arrangements whether written, oral or implied between the Company or Veoneer and the Executive relating to the employment of the Executive, without prejudice to any rights accrued to the Company or the Executive prior to the commencement of his employment under this Agreement.
16.Disputes. Disputes regarding this Agreement (including, without limitation, disputes regarding the existence of Cause or Good Reason) shall be settled by arbitration in accordance with the Swedish Arbitration Act. The arbitration shall take place in Stockholm and, unless otherwise agreed to by both parties, there shall be three (3) arbitrators. The provisions on voting and cumulation of parties and claims in the Swedish Procedural Code shall be applied in the arbitration. All costs and expenses for the arbitration, whether initiated by the Company or by the Executive, including the Executive’s costs for solicitor, shall be borne by the Company, unless the arbitrators determine the Executive’s claim(s) to be frivolous and in bad faith, in which case the arbitrators may allocate costs as they deem fit. Any payments due to the Executive pursuant to the preceding sentence shall be made within fifteen (15) business days after delivery of the Executive’s written request for payment accompanied with such evidence of costs and expenses incurred as the Company reasonably may require.
17.Governing Law. This Agreement shall be governed by and construed in accordance with Swedish law and, where applicable, the laws of any applicable local jurisdictions.
18.Amendment. No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing and signed by the Executive and such officer as may be specifically designated by the Board.
19.Notices. All notices and other communications hereunder shall be in writing and shall be given by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 
If to the Executive:  Christer Lundström


If to the Company: Veoneer Inc.
           WTC, Klarabergsviadukten 70,
        111 64 Stockholm, Sweden

or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee.
20.U.S. Tax Code Section 409A. This Section 20 shall apply only in the event that the Executive is or becomes a taxpayer under the laws of the United States at any time during the Employment Period.
(a)General. This Agreement shall be interpreted and administered in a manner so that any amount or benefit payable hereunder shall be paid or provided in a manner that is either exempt from or compliant with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and applicable Internal Revenue Service guidance and Treasury Regulations issued thereunder. Nevertheless, the tax treatment of the benefits provided under the Agreement is not warranted or guaranteed. Neither the Company nor its directors, officers, employees or advisers shall be held liable for any taxes, interest, penalties or other monetary amounts owed by the Executive as a result of the application of Section 409A of the Code.
(b)Definitional Restrictions. Notwithstanding anything in this Agreement to the contrary, to the extent that any amount or benefit that would constitute non-exempt “deferred compensation” for purposes of
- 7 -


Section 409A of the Code (“Non-Exempt Deferred Compensation”) would otherwise be payable or distributable hereunder, or a different form of payment of such Non-Exempt Deferred Compensation would be effected, by reason of a Change in Control or the Executive’s termination of employment, such Non-Exempt Deferred Compensation will not be payable or distributable to the Executive, and/or such different form of payment will not be effected, by reason of such circumstance unless the circumstances giving rise to such Change in Control or termination of employment, as the case may be, meet any description or definition of “change in control event” or “separation from service,” as the case may be, in Section 409A of the Code and applicable regulations (without giving effect to any elective provisions that may be available under such definition). This provision does not prohibit the vesting of any Non-Exempt Deferred Compensation upon a Change in Control or termination of employment, however defined. If this provision prevents the payment or distribution of any Non-Exempt Deferred Compensation, such payment or distribution shall be made on the date, if any, on which an event occurs that constitutes a Section 409A-compliant “change in control event” or “separation from service,” as the case may be, or such later date as may be required by subsection (c) below. If this provision prevents the application of a different form of payment of any amount or benefit, such payment shall be made in the same form as would have applied absent such designated event or circumstance.
(c)Six-Month Delay in Certain Circumstances. Notwithstanding anything in this Agreement to the contrary, if any amount or benefit that would constitute Non-Exempt Deferred Compensation would otherwise be payable or distributable under this Agreement by reason of the Executive’s separation from service during a period in which he is a “specified employee” (as defined in Code Section 409A and the final regulations thereunder), then, subject to any permissible acceleration of payment by the Company under Treas. Reg. Section 1.409A3(j)(4)(ii) (domestic relations order), (j)(4)(iii) (conflicts of interest), or (j)(4)(vi) (payment of employment taxes), (i) the amount of such Non-Exempt Deferred Compensation that would otherwise be payable during the six-month period immediately following the Executive’s separation from service will be accumulated through and paid or provided on the first day of the seventh month following the Executive’s separation from service (or, if the Executive dies during such period, within thirty (30) days after the Executive’s death) (in either case, the “Required Delay Period”); and (ii) the normal payment or distribution schedule for any remaining payments or distributions will resume at the end of the Required Delay Period.
(d)Treatment of Installment Payments. Each payment of termination benefits under this Agreement shall be considered a separate payment, as described in Treas. Reg. Section 1.409A2(b)(2), for purposes of Section 409A of the Code.
(e)Timing of Release of Claims. Whenever in this Agreement a payment or benefit is conditioned on the Executive’s execution and non-revocation of a release of claims, such as the separation agreement referenced in Section 11(a) hereof, such release must be executed and all revocation periods shall have expired within 60 days after the Date of Termination; failing which such payment or benefit shall be forfeited. If such payment or benefit constitutes Non-Exempt Deferred Compensation, then, subject to subsection (c) above, such payment or benefit (including any installment payments) that would have otherwise been payable during such 60-day period shall be accumulated and paid on the 60th day after the Date of Termination provided such release shall have been executed and such revocation periods shall have expired. If such payment or benefit is exempt from Section 409A of the Code, the Company may elect to make or commence payment at any time during such 60-day period.
(f)Timing of Reimbursements and In-kind Benefits. If the Executive is entitled to be paid or reimbursed for any taxable expenses under this Agreement and if such payments or reimbursements are includible in the Executive’s federal gross taxable income, the amount of such expenses payable or reimbursable in any one calendar year shall not affect the amount payable or reimbursable in any other calendar year, and the reimbursement of an eligible expense must be made no later than December 31 of the year after the year in which the expense was incurred. The right to any reimbursement for expenses incurred or provision of in-kind benefits is limited to the lifetime of the Executive, or such shorter period of time as is provided with respect to each particular right to reimbursement in-kind benefits pursuant to the preceding provisions of this Agreement. No right of the Executive to reimbursement of expenses under this Agreement shall be subject to liquidation or exchange for another benefit.
- 8 -



IN WITNESS whereof this Agreement has been executed the day and year first above written.



/s/ Christer Lundström
Christer Lundström



Veoneer, Inc.

/s/ Jan Carlson
Jan Carlson
Chairman and CEO, Veoneer, Inc.



Veoneer, Inc.

/s/ Mikael Landberg
Mikael Landberg
Executive Vice President Human Resources
- 9 -

Exhibit 31.1
CERTIFICATION of
the Chief Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Jan Carlson, certify that:
1.I have reviewed this quarterly report on Form 10-Q of VEONEER, INC.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a -15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
July 24, 2020
 
/s/ Jan Carlson
Jan Carlson
President and Chief Executive Officer



Exhibit 31.2
CERTIFICATION of
the Chief Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Mats Backman, certify that:
1.I have reviewed this quarterly report on Form 10-Q of VEONEER, INC.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a -15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;  
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
July 24, 2020
 
/s/ Mats Backman
Mats Backman
Chief Financial Officer



Exhibit 32.1
Certification of Chief Executive Officer
Pursuant to 18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the quarterly report on Form 10-Q of Veoneer, Inc. (the “Company”) for the period ended June 30, 2020, filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jan Carlson, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

July 24, 2020
 
 
/s/ Jan Carlson
Jan Carlson
President and Chief Executive Officer
 
This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.


Exhibit 32.2
Certification of Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the quarterly report on Form 10-Q of Veoneer, Inc. (the “Company”) for the period ended June 30, 2020, filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mats Backman, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

July 24, 2020
 
 
/s/ Mats Backman
Mats Backman
Chief Financial Officer
 
This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.